[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 341
1. Saliba I, Evrard AS: Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J; 2009;2:6508
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series.
  • INTRODUCTION: Middle ear glandular neoplasms are infrequent causes of a middle ear mass.
  • It is currently thought that these tumors are indistinguishable each from another.
  • Herein, we present a new case of a middle ear glandular neoplasm.
  • Our objective is to review all cases described in the literature in order to identify the clinical features, the gross pathology, the histopathology, the immunohistochemistry, to discuss the differential diagnosis, the treatment, the rate of recurrence, the follow-up, the incidence of metastasis, the prognosis and to present a new classification of middle ear glandular neoplasm.
  • We uncovered 75 patients with a carcinoid tumor and 19 patients with a middle ear adenoma diagnosis; the most common presenting symptom was a conductive hearing loss.
  • The tumor's cells are immunohistochemically positive for a variety of keratin antibodies and most of them are also positive for neuroendocrine markers.
  • CONCLUSIONS: Our study and the review of the literature showed adenomas and carcinoid tumors of the middle ear to be essentially indistinguishable benign tumors with metastatic potential.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Otolaryngol Allied Sci. 1976;1(1):17-26 [1031337.001]
  • [Cites] Auris Nasus Larynx. 2009 Feb;36(1):75-8 [18328653.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1989 Sep;98(9):749-52 [2782809.001]
  • [Cites] Acta Pathol Jpn. 1988 Nov;38(11):1453-60 [3223280.001]
  • [Cites] J Laryngol Otol. 1987 May;101(5):480-6 [3585164.001]
  • [Cites] Am J Clin Pathol. 1980 Jun;73(6):816-23 [6156597.001]
  • [Cites] Ann Pathol. 1993;13(3):170-5 [7691060.001]
  • [Cites] Histopathology. 1997 Apr;30(4):359-64 [9147085.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(2):57-61 [9550256.001]
  • [Cites] Histopathology. 1998 Mar;32(3):279-80 [9568517.001]
  • [Cites] Head Neck. 1999 Jan;21(1):72-7 [9890354.001]
  • [Cites] Pathology. 1999 Aug;31(3):284-7 [10503278.001]
  • [Cites] Neuroradiology. 2001 Jan;43(1):58-61 [11214650.001]
  • [Cites] Mod Pathol. 2002 May;15(5):543-55 [12011260.001]
  • [Cites] Acta Otolaryngol. 2003 Aug;123(6):678-82 [12953765.001]
  • [Cites] Acta Otolaryngol. 2004 Aug;124(6):754-7 [15515504.001]
  • [Cites] Head Neck. 2005 Jul;27(7):644-7 [15825200.001]
  • [Cites] Laryngoscope. 2005 Sep;115(9):1660-6 [16148713.001]
  • [Cites] Ear Nose Throat J. 2005 Sep;84(9):560-1 [16261754.001]
  • [Cites] Oral Oncol. 2006 Sep;42(8):770-88 [16815077.001]
  • [Cites] Clin Nucl Med. 2007 Jun;32(6):466-7 [17515757.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1990 Jul;99(7 Pt 1):547-52 [2164339.001]
  • (PMID = 20111612.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2812983
  •  go-up   go-down


2. Tok EC, Ertunc D, Tataroglu C, Yazici G, Kanat H, Dilek S: Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women. Int J Gynecol Cancer; 2006 Mar-Apr;16(2):501-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The study group consisted of 184 women who were operated for benign gynecological conditions.
  • SHPP was found to be related with age, menarche-to-operation time, history, and the duration of oral contraceptive use.
  • [MeSH-major] Neoplasms, Glandular and Epithelial / pathology. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cohort Studies. Contraceptives, Oral. Female. Humans. Menopause. Middle Aged. Neoplasm Invasiveness. Ovariectomy. Phenotype. Precancerous Conditions / pathology. Reproduction / physiology. Risk Factors. Surveys and Questionnaires

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681718.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contraceptives, Oral
  •  go-up   go-down


3. Saleh HA, Clayman L, Masri H: Fine needle aspiration biopsy of intraoral and oropharyngeal mass lesions. Cytojournal; 2008;5:4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Fine needle aspiration (FNA) biopsy has been rarely used in oral and oropharyngeal lesions.
  • The goal of this study was to assess the value and accuracy of FNA biopsy in the diagnosis of oral and oropharyngeal lesions particularly in regards to discriminating benign from malignant tumors.
  • The sites of involvement were: lip 1, maxillary sinus 3, pharynx/oropharynx 5, floor of mouth 4, buccal mucosa 2 and peritonsillar area 1.
  • Cytologically, 7 cases were diagnosed as suspicious/malignant, and 9 cases as benign (including 6 benign neoplasm, 1 atypical, and 2 reactive or "descriptive").
  • Fifteen cases had corresponding surgical resection for histologic examination, of these, 9 cases were interpreted as malignant, and 6 as benign.
  • Two cases were interpreted as benign or atypical cytologically, but were found to be malignant on histologic examination.
  • Furthermore, aspiration biopsy is an important tool in the diagnosis and management of these lesions, both neoplastic and non-neoplastic, and can be sometimes complemented by ancillary studies for more accurate interpretation.
  • However, its sensitivity in the diagnosis of malignancy is lower than that of histologic samples.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2003 Apr 25;99(2):105-12 [12704690.001]
  • [Cites] Acta Cytol. 2003 Nov-Dec;47(6):1127-30 [14674096.001]
  • [Cites] Acta Otolaryngol. 2004 Mar;124(2):213-6 [15072428.001]
  • [Cites] J Craniofac Surg. 2004 Nov;15(6):1056-60 [15547405.001]
  • [Cites] Diagn Cytopathol. 2005 Jan;32(1):11-5 [15584054.001]
  • [Cites] Auris Nasus Larynx. 2005 Sep;32(3):301-4 [15923100.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Jun;63(6):805-10 [15944978.001]
  • [Cites] J Oral Pathol Med. 2007 Apr;36(4):207-14 [17391298.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Sep;66(3):323-33 [2845326.001]
  • [Cites] Acta Cytol. 1987 Jul-Aug;31(4):471-5 [3037832.001]
  • [Cites] Cancer. 1988 Dec 15;62(12):2602-6 [3191460.001]
  • [Cites] Acta Cytol. 1995 Jul-Aug;39(4):683-8 [7543234.001]
  • [Cites] Head Neck. 1995 Mar-Apr;17(2):124-30 [7558809.001]
  • [Cites] Acta Cytol. 1993 Jul-Aug;37(4):448-50 [8328237.001]
  • [Cites] Acta Cytol. 1993 May-Jun;37(3):333-42 [8388607.001]
  • [Cites] Acta Cytol. 1997 Sep-Oct;41(5):1407-11 [9305377.001]
  • [Cites] Diagn Cytopathol. 1998 Sep;19(3):229-34 [9841139.001]
  • [Cites] Diagn Cytopathol. 1999 Mar;20(3):167-9 [10086243.001]
  • [Cites] Laryngoscope. 1999 Aug;109(8):1232-7 [10443825.001]
  • [Cites] Diagn Cytopathol. 2000 Mar;22(3):139-46 [10679992.001]
  • [Cites] Mod Pathol. 2002 Mar;15(3):342-50 [11904347.001]
  • [Cites] Cytopathology. 2002 Oct;13(5):309-16 [12421447.001]
  • [Cites] Acta Cytol. 2003 Mar-Apr;47(2):275-80 [12685201.001]
  • (PMID = 18373853.001).
  • [ISSN] 1742-6413
  • [Journal-full-title] CytoJournal
  • [ISO-abbreviation] Cytojournal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2329665
  •  go-up   go-down


Advertisement
4. Ogütcen-Toller M, Sener I, Kasap V, Cakir-Ozkan N: Maxillary myxoma: surgical treatment and reconstruction with buccal fat pad flap: a case report. J Contemp Dent Pract; 2006 Feb 15;7(1):107-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myxoma is a benign tumor that arises from mesenchymal tissue and is found less commonly in the bone than in soft tissue.
  • When compared with other odontogenic tumors, myxoma of the jaws is a rare entity.
  • Numerous types of treatment have been used for these tumors including simple curettage, enucleation, curettage with peripheral ostectomy, and en bloc resection with or without immediate reconstruction.
  • [MeSH-major] Adipose Tissue / transplantation. Maxillary Neoplasms / surgery. Myxoma / surgery. Oral Surgical Procedures / methods
  • [MeSH-minor] Adult. Bone Substitutes. Bone Transplantation. Cheek. Female. Follow-Up Studies. Humans. Neoplasm Invasiveness. Oroantral Fistula / surgery. Reconstructive Surgical Procedures. Surgical Flaps. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16491153.001).
  • [ISSN] 1526-3711
  • [Journal-full-title] The journal of contemporary dental practice
  • [ISO-abbreviation] J Contemp Dent Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Substitutes; 0 / OsteoGraf-N
  •  go-up   go-down


5. Hong R, Lim SC: Granular cell tumor of the cecum with extensive hyalinization and calcification: a case report. World J Gastroenterol; 2009 Jul 14;15(26):3315-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor of the cecum with extensive hyalinization and calcification: a case report.
  • A granular cell tumor (GCT) is a benign neoplasm of unclear histogenesis that is generally believed to be of nerve sheath origin.
  • In addition to the tumor, endoscopic examination revealed the presence of a 5-mm-polyp in the descending colon and multiple tiny polyps in the sigmoid colon and rectum.
  • Histological examination demonstrated a cecal tumor 1.5 cm x 1.0 cm x 0.7 cm with a hard consistency; in cut sections, mixed cells with yellowish and whitish portions were seen.
  • The tumor was located between the mucosa and subserosa, and was composed of plump histiocyte-like tumor cells with abundant granular eosinophilic cytoplasm, which were immunoreactive for S-100 protein, vimentin, neuron-specific enolase, inhibin-alpha and calretinin.
  • The tumor showed extensive hyalinization and focal dystrophic calcification.
  • Extensive hyalinization and calcification showing involution of tumor cells suggest benign clinical behavior of GCT.
  • [MeSH-major] Calcinosis / pathology. Cecum / pathology. Granular Cell Tumor / pathology. Hyalin / metabolism
  • [MeSH-minor] Biomarkers, Tumor. Calbindin 2. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / pathology. Humans. Male. Middle Aged. Phosphopyruvate Hydratase. S100 Calcium Binding Protein G. S100 Proteins. Vimentin

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ugeskr Laeger. 2006 May 22;168(21):2080-1 [16768929.001]
  • [Cites] J Oral Pathol Med. 1997 Apr;26(4):164-9 [9176790.001]
  • [Cites] J Craniofac Surg. 2008 Nov;19(6):1691-4 [19098584.001]
  • [Cites] J Oral Pathol Med. 2009 Jan;38(1):150-9 [19192059.001]
  • [Cites] J Gastroenterol. 2000;35(8):631-4 [10955603.001]
  • [Cites] Am J Surg Pathol. 2001 Sep;25(9):1200-3 [11688581.001]
  • [Cites] J Gastroenterol. 2003;38(4):385-9 [12743780.001]
  • [Cites] World J Gastroenterol. 2004 Aug 15;10(16):2452-4 [15285042.001]
  • [Cites] Mt Sinai J Med. 1979 Mar-Apr;46(2):195-8 [220528.001]
  • [Cites] J Surg Oncol. 1980;13(4):301-16 [6246310.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Apr;65(4):427-35 [2834681.001]
  • [Cites] Am J Gastroenterol. 1989 Jun;84(6):656-9 [2543214.001]
  • [Cites] Am J Gastroenterol. 1993 Feb;88(2):311-5 [8424442.001]
  • [Cites] Am J Gastroenterol. 1993 Oct;88(10):1785-7 [8213726.001]
  • [Cites] Pathologica. 1995 Apr;87(2):175-8 [8532413.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Dec;80(6):687-97 [8680977.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 1997 Jan;94(1):27-32 [9028140.001]
  • [Cites] Turk J Gastroenterol. 2008 Mar;19(1):73-4 [18386247.001]
  • (PMID = 19598311.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G; 0 / S100 Proteins; 0 / Vimentin; EC 4.2.1.11 / Phosphopyruvate Hydratase
  • [Other-IDs] NLM/ PMC2710791
  •  go-up   go-down


6. Teh SH, Tseng D, Sheppard BC: Laparoscopic and open distal pancreatic resection for benign pancreatic disease. J Gastrointest Surg; 2007 Sep;11(9):1120-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic and open distal pancreatic resection for benign pancreatic disease.
  • The aim of the study is to provide comparisons of the perioperative outcomes between open and laparoscopic distal pancreatic resection (DPR) for benign pancreatic disease.
  • From 2002 and 2005, there were 28 patients (16 open, 12 laparoscopic) with a mean age of 52 who had presumptive diagnoses of benign pancreatic lesions.
  • Pathology was neuroendocrine tumor (nine and five), mucinous cystic neoplasm (three and three), symptomatic pancreatic pseudocyst (two and two), and others (two and two).
  • Ten of 12 patients (83%) with laparoscopic DPR had adequate oral intake within 72 h post operatively in contrast to 2 of 16 (12.5%) patients in the open DPR group (p = 0.0001).
  • In centers with the appropriate expertise, laparoscopic DPR should be considered the procedure of choice for putative benign lesions of the pancreatic body and tail.

  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 1999 May;229(5):693-8; discussion 698-700 [10235528.001]
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Surg Clin North Am. 2000 Aug;80(4):1151-70 [10987029.001]
  • [Cites] Surgery. 1996 Dec;120(6):1051-4 [8957494.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2004 Aug;14(4):181-5 [15472543.001]
  • [Cites] Am J Surg. 1995 Feb;169(2):208-12; discussion 212-3 [7840381.001]
  • [Cites] Transplantation. 1997 Jan 27;63(2):229-33 [9020322.001]
  • [Cites] Surgery. 2005 Jun;137(6):597-605 [15962401.001]
  • [Cites] Br J Surg. 1999 May;86(5):608-11 [10361178.001]
  • [Cites] Ann Surg. 1995 Feb;221(2):156-64 [7857143.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):996-1003 [12163971.001]
  • [Cites] Cancer J. 2005 Jan-Feb;11(1):43-51 [15831223.001]
  • [Cites] Ann Surg. 1996 Mar;223(3):280-5 [8604908.001]
  • [Cites] Ann Surg. 2005 Jun;241(6):919-26; discussion 926-8 [15912041.001]
  • [Cites] Ann Surg Oncol. 2001 Apr;8(3):249-53 [11314942.001]
  • [Cites] World J Surg. 1998 May;22(5):494-8 [9564295.001]
  • [Cites] Surgery. 2003 Jul;134(1):45-52 [12874582.001]
  • [Cites] Ann Surg. 2002 Aug;236(2):149-58 [12170019.001]
  • [Cites] Hepatogastroenterology. 2005 Mar-Apr;52(62):620-4 [15816491.001]
  • [Cites] World J Surg. 2002 Aug;26(8):1057-65 [12016486.001]
  • [Cites] Br J Surg. 2003 Feb;90(2):190-6 [12555295.001]
  • [Cites] Br J Surg. 2004 Aug;91(8):975-82 [15286957.001]
  • [Cites] Surg Endosc. 2005 Aug;19(8):1028-34 [16027987.001]
  • [Cites] J Gastrointest Surg. 2004 May-Jun;8(4):493-501 [15120376.001]
  • (PMID = 17623260.001).
  • [ISSN] 1091-255X
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ: Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev; 2007 Jul;16(7):1348-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we evaluate soluble CD44 (solCD44) as an early detection tool for HNSCC by determining whether it reliably distinguishes HNSCC from benign disease of the upper aerodigestive tract.
  • METHODS: We carried out the solCD44 ELISA on oral rinses from 102 patients with HNSCC and 69 control patients with benign diseases of upper aerodigestive tract to determine the sensitivity and specificity of the test for differentiating HNSCC from benign disease.
  • Furthermore, we did a pilot study using methylation-specific PCR primers on oral rinses from 11 HNSCC patients with low solCD44 levels and 10 benign disease controls.
  • RESULTS: Mean salivary solCD44 levels were 24.4 +/- 32.0 ng/mL for HNSCC patients (range, 0.99-201 ng/mL) and 9.9 +/- 16.1 ng/mL (range, 0.73-124 ng/mL) for the patients with benign disease (P < 0.0001).
  • CONCLUSIONS: SolCD44 is elevated in the majority of HNSCC and distinguishes cancer from benign disease with high specificity.
  • [MeSH-major] Antigens, CD44 / metabolism. Biomarkers, Tumor / metabolism. Carcinoma, Squamous Cell / metabolism. Head and Neck Neoplasms / metabolism
  • [MeSH-minor] Case-Control Studies. DNA Methylation. Enzyme-Linked Immunosorbent Assay. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Pilot Projects. Prognosis. Saliva / metabolism. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17627000.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA107828
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Biomarkers, Tumor; 0 / CD44 protein, human
  •  go-up   go-down


8. Ghazali N, Cascarini L, Norris P, Barrett AW, Lavery KM: Perivascular epithelioid cell tumor (PEComa) of the cheek. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul;110(1):e26-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perivascular epithelioid cell tumor (PEComa) of the cheek.
  • We present the unusual case of a perivascular epithelioid cell tumor (PEComa) occurring within the cheek of a 32-year-old woman.
  • PEComa is a rare, recently described, family of tumors with diverse clinicopathologic expression and which express melanocytic and muscle markers.
  • Other possible diagnoses considered included benign mesenchymal tumors of smooth muscle or neural origin.
  • The tumor was completely excised, but in view of uncertainty as to how this entity would behave in an unusual location, lifelong follow up is recommended.
  • [MeSH-major] Cheek / pathology. Facial Neoplasms / diagnosis. Perivascular Epithelioid Cell Neoplasms / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Actins / analysis. Adult. Antigens, Neoplasm / analysis. Arterioles / pathology. Diagnosis, Differential. Epithelioid Cells / pathology. Female. Follow-Up Studies. Humans. MART-1 Antigen. Muscle, Smooth, Vascular / pathology. Neoplasm Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20610292.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, Neoplasm; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Neoplasm Proteins
  •  go-up   go-down


9. Shivakumar S, Prabhakar BT, Jayashree K, Rajan MG, Salimath BP: Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast. J Cancer Res Clin Oncol; 2009 Apr;135(4):627-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A great deal of interest has been paid to the predictive value of neoangiogenesis represented by microvessel density (MVD), on clinical progression and prognosis of several types of tumors.
  • Serum VEGF levels may therefore be clinically useful for the prediction of increase in tumor growth, metastasis or recurrence spread in individual patients.
  • The expressed serum VEGF levels and microvessel density (MVD) were assessed quantitatively and were correlated with tumor grade, tumor necrosis, stromal reaction and nodal metastasis.
  • RESULTS: Serum VEGF was increased in patients with lesions of breast and the levels of serum VEGF in malignant lesions were significantly increased when compared to benign lesions.
  • MVD showed a significant correlation in the early stages of the malignant tumors, where there was no necrosis, but in tumors associated with necrosis and hemorrhage MVD failed to show significant correlation.
  • CONCLUSION: Hence, serum vascular endothelial growth factor can be used as a more reliable, non-invasive adjunctive diagnostic criteria in the assessment of the grade and hence, the prognosis of malignant tumors of the breast.
  • [MeSH-major] Breast Neoplasms / blood supply. Breast Neoplasms / pathology. Microvessels / pathology. Prognosis. Vascular Endothelial Growth Factor A / blood
  • [MeSH-minor] Animals. Antibodies. Biomarkers / blood. Biomarkers, Tumor / blood. Enzyme-Linked Immunosorbent Assay. Female. Humans. Neoplasm Staging. Neovascularization, Pathologic / pathology. Rabbits. Reproducibility of Results. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 1999 Jan;79(2):363-9 [9888482.001]
  • [Cites] Arch Pathol Lab Med. 2000 Jul;124(7):966-78 [10888772.001]
  • [Cites] Clin Cancer Res. 1996 May;2(5):821-6 [9816236.001]
  • [Cites] Nat Med. 1995 Jan;1(1):27-31 [7584949.001]
  • [Cites] Cancer Res. 1995 Sep 15;55(18):3964-8 [7664263.001]
  • [Cites] Science. 1994 Sep 9;265(5178):1582-4 [7521539.001]
  • [Cites] Ann Surg. 2003 Jul;238(1):9-28 [12832961.001]
  • [Cites] Int J Cancer. 1998 Apr 17;79(2):144-6 [9583728.001]
  • [Cites] Eur J Intern Med. 2003 Dec;14(8):459-469 [14962697.001]
  • [Cites] J Biol Chem. 1995 Aug 25;270(34):19761-6 [7544346.001]
  • [Cites] J Comp Pathol. 2004 Feb-Apr;130(2-3):99-104 [15003465.001]
  • [Cites] Cancer Lett. 1997 Nov 11;119(2):227-35 [9570376.001]
  • [Cites] Br J Cancer. 1997;76(9):1221-7 [9365173.001]
  • [Cites] Endocr Rev. 1997 Feb;18(1):4-25 [9034784.001]
  • [Cites] Intern Med. 2005 Jan;44(1):26-34 [15704659.001]
  • [Cites] Mol Endocrinol. 1991 Dec;5(12):1806-14 [1791831.001]
  • [Cites] Pharmacol Ther. 1994 Sep;63(3):265-311 [7530374.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Jan;33(1):2-7 [14690652.001]
  • [Cites] Nat Med. 2000 Apr;6(4):389-95 [10742145.001]
  • [Cites] Cancer Res. 2001 Jul 15;61(14):5407-14 [11454684.001]
  • [Cites] Science. 1983 Feb 25;219(4587):983-5 [6823562.001]
  • [Cites] Science. 1992 Feb 21;255(5047):989-91 [1312256.001]
  • [Cites] Br J Cancer. 1997;76(2):238-43 [9231925.001]
  • [Cites] Clin Cancer Res. 2004 Mar 1;10(5):1706-16 [15014023.001]
  • [Cites] Eur J Cancer. 1996 Dec;32A(14):2474-84 [9059336.001]
  • [Cites] Br J Cancer. 1999 Oct;81(4):727-32 [10574263.001]
  • [Cites] Cancer Metastasis Rev. 1993 Sep;12(3-4):303-24 [8281615.001]
  • [Cites] Am J Pathol. 1993 Nov;143(5):1255-62 [8238242.001]
  • [Cites] CA Cancer J Clin. 2000 Jan-Feb;50(1):7-33 [10735013.001]
  • [Cites] BJU Int. 2001 Jun;87(9):866-75 [11412229.001]
  • [Cites] J Natl Cancer Inst. 1995 Apr 5;87(7):506-16 [7707437.001]
  • [Cites] Hum Pathol. 2004 Sep;35(9):1053-7 [15343505.001]
  • [Cites] Nature. 2000 Sep 14;407(6801):249-57 [11001068.001]
  • [Cites] Ann Oncol. 1996 Oct;7(8):843-8 [8922199.001]
  • [Cites] Angiogenesis. 2002;5(1-2):15-20 [12549856.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 Jul;34(5):559-65 [16053878.001]
  • [Cites] J Clin Oncol. 1998 Sep;16(9):3121-8 [9738584.001]
  • [Cites] Blood. 1997 Oct 15;90(8):3167-72 [9376599.001]
  • [Cites] Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579-86 [1417831.001]
  • [Cites] Breast Cancer Res Treat. 1999 Jan;53(2):161-6 [10326793.001]
  • [Cites] Head Neck. 2002 Jul;24(7):643-50 [12112537.001]
  • [Cites] Int J Cancer. 1993 Nov 11;55(5):739-44 [8244569.001]
  • [Cites] Ann Surg Oncol. 2007 Jun;14(6):1835-45 [17406950.001]
  • [Cites] Cell. 1994 Oct 21;79(2):185-8 [7525076.001]
  • [Cites] N Engl J Med. 1991 Jan 3;324(1):1-8 [1701519.001]
  • [Cites] Breast Cancer Res Treat. 1995;36(2):127-37 [8534862.001]
  • (PMID = 18936974.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies; 0 / Biomarkers; 0 / Biomarkers, Tumor; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


10. Jundt G, Reichart PA: [Malignant odontogenic tumors]. Pathologe; 2008 May;29(3):205-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Malignant odontogenic tumors].
  • Malignant odontogenic tumors are extremely rare.
  • As with benign odontogenic tumors, malignant epithelial odontogenic tumors or odontogenic carcinomas are distinguished from the even rarer mesenchymal ones, the odontogenic sarcomas.
  • Whereas metastasizing ameloblastoma can be diagnosed only after having metastasized, all other malignant odontogenic tumors present with atypia, increased cellularity and mitoses, and invasion.
  • Odontogenic sarcomas are regarded as low-grade tumors that rarely metastasize.
  • [MeSH-major] Jaw Neoplasms / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Ameloblastoma / classification. Ameloblastoma / pathology. Carcinoma / classification. Carcinoma / pathology. Carcinosarcoma / classification. Carcinosarcoma / pathology. Diagnosis, Differential. Humans. Jaw / pathology. Neoplasm Invasiveness. Sarcoma / classification. Sarcoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Craniomaxillofac Surg. 2005 Oct;33(5):352-5 [16129612.001]
  • [Cites] J Dent Res. 2003 Jul;82(7):551-7 [12821718.001]
  • [Cites] Dentomaxillofac Radiol. 2004 May;33(3):152-7 [15371314.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Jan;36(1):20-5 [17156974.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1994;30B(2):126-31 [7913362.001]
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):123-30 [551398.001]
  • [Cites] J Oral Pathol Med. 1998 Feb;27(2):59-63 [9526730.001]
  • [Cites] Int J Oral Maxillofac Surg. 2001 Aug;30(4):349-55 [11518362.001]
  • [Cites] J Oral Pathol Med. 2005 May;34(5):318-20 [15817077.001]
  • [Cites] J Craniofac Surg. 2003 May;14(3):356-62 [12826807.001]
  • [Cites] Dtsch Z Mund Kiefer Gesichtschir. 1991 Mar-Apr;15(2):90-3 [1816940.001]
  • [Cites] Pathol Res Pract. 1983 Aug;178(1):40-7 [6227872.001]
  • [Cites] Hua Xi Yi Ke Da Xue Xue Bao. 1998 Dec;29(4):390-3 [10743235.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] Rev Stomatol Chir Maxillofac. 2003 Oct;104(5):265-73 [14679345.001]
  • [Cites] Pathol Res Pract. 1985 Nov;180(5):526-35 [4080638.001]
  • [Cites] J Oral Maxillofac Surg. 2003 May;61(5):580-6 [12730837.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Feb;61(2):256-8 [12619007.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul;104(1):72-5 [17577546.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Apr;103(4):516-20 [17395065.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Sep;65(9):1820-4 [17719405.001]
  • [Cites] Arch Pathol Lab Med. 1993 Nov;117(11):1126-31 [8239934.001]
  • [Cites] Mod Pathol. 2004 Sep;17 (9):1062-7 [15133474.001]
  • [Cites] Head Neck. 2005 Jun;27(6):536-42 [15772956.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):194-200 [16448921.001]
  • [Cites] J Craniofac Surg. 2004 Mar;15(2):264-9 [15167247.001]
  • [Cites] Virchows Arch. 2001 Apr;438(4):412-7 [11355179.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1977 Mar;43(3):391-401 [265043.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1995 Jun;121(6):685-9 [7772324.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jan;103(1):72-6 [17178497.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):170-6 [10468461.001]
  • [Cites] J Oral Pathol Med. 1989 Feb;18(2):113-8 [2746520.001]
  • [Cites] Med Oral. 2001 May-Jul;6(3):173-9 [11500634.001]
  • (PMID = 18392827.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


11. Canjuga I, Mravak-Stipetić M, Kopić V, Galić J: Oral acanthosis nigricans: case report and comparison with literature reports. Acta Dermatovenerol Croat; 2008;16(2):91-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral acanthosis nigricans: case report and comparison with literature reports.
  • Acanthosis nigricans (AN) is a rare condition which may affect oral cavity.
  • There are two forms of AN: benign and malignant.
  • Benign AN may be hereditary, or may be related to systemic diseases or drugs.
  • Oral lesions occurred after the tumor had been diagnosed, i.e. after third operation for tumor recurrence.
  • The fifth operation for tumor recurrence resulted in slight improvement of oral changes.
  • It is concluded that the severity of oral changes is in correlation with tumor progression.
  • The occurrence of oral lesions may be an indicator of tumor progression.
  • [MeSH-major] Acanthosis Nigricans / etiology. Acanthosis Nigricans / pathology. Carcinoma, Transitional Cell / complications. Mouth Diseases / etiology. Mouth Diseases / pathology. Urinary Bladder Neoplasms / complications
  • [MeSH-minor] Aged. Disease Progression. Female. Humans. Neoplasm Recurrence, Local / surgery. Reoperation. Severity of Illness Index

  • Genetic Alliance. consumer health - Acanthosis Nigricans.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18541106.001).
  • [ISSN] 1330-027X
  • [Journal-full-title] Acta dermatovenerologica Croatica : ADC
  • [ISO-abbreviation] Acta Dermatovenerol Croat
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 20
  •  go-up   go-down


12. Moreira PR, Guimarães MM, Guimarães AL, Diniz MG, Gomes CC, Brito JA, Gomez RS: Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med; 2009 Jan;38(1):99-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Odontogenic keratocyst (OKC) is a benign neoplasm with an aggressive clinical behavior and a high recurrence rate.
  • Although epigenetic alterations have been reported in different tumors, these events were not investigated in OKC yet.
  • The aim of this study was to investigate the presence of methylation in P16, P21, P27, P53 and RB1 genes in OKC tumors.
  • METHODS: Methylation-specific polymerase chain reaction (MSP) was used to evaluate the presence of methylation in 10 samples of OKCs, 10 samples of dental follicles and six samples of normal mucosa.
  • [MeSH-major] DNA Methylation / genetics. Genes, Tumor Suppressor. Odontogenic Cysts / genetics
  • [MeSH-minor] Adolescent. Adult. Child. Cyclin-Dependent Kinase Inhibitor p21 / genetics. Cyclin-Dependent Kinase Inhibitor p27 / genetics. Dental Sac / metabolism. Epigenesis, Genetic / genetics. Female. Genes, p16. Genes, p53. Humans. Male. Mouth Mucosa / metabolism. Promoter Regions, Genetic / genetics. Retinoblastoma Protein / genetics. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19192054.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Retinoblastoma Protein; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27
  •  go-up   go-down


13. Kousar A, Hosein MM, Ahmed Z, Minhas K: Rapid sarcomatous transformation of an ameloblastic fibroma of the mandible: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep;108(3):e80-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastic fibrosarcoma (AFS) is a rare malignant odontogenic tumour regarded as the malignant counterpart of ameloblastic fibroma.
  • It is characterized by a benign epithelial component within a malignant fibrous stroma.
  • AFS is a locally aggressive neoplasm with extremely low potential for metastasis.
  • Initially histopathologically diagnosed as a benign lesion, it rapidly recurred with apparent transformation into a high-grade sarcoma over a period of 6 months.
  • [MeSH-major] Cell Transformation, Neoplastic / pathology. Mandibular Neoplasms / pathology. Odontogenic Tumors / pathology. Sarcoma / pathology
  • [MeSH-minor] Brain Neoplasms / secondary. Fatal Outcome. Female. Follow-Up Studies. Humans. Lung Neoplasms / secondary. Masseter Muscle / pathology. Muscle Neoplasms / pathology. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Radiography, Panoramic. Skull Neoplasms / pathology. Sphenoid Bone / pathology. Tomography, X-Ray Computed. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19716496.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  •  go-up   go-down


14. Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I, De Gendt S, de Hemptinne B: The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc; 2008 Jan;22(1):38-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The value of laparoscopic liver surgery for solid benign hepatic tumors.
  • BACKGROUND: Laparoscopic liver resection (LLR) has gained wide acceptance for various liver resection procedures, mainly for benign diseases.
  • The indication was solid benign liver tumor in 56 (8.9%) patients.
  • LLR was characterized by faster time to first oral intake and shorter hospital stay compared to OS (p = 0.001 and 0.008, respectively).
  • CONCLUSIONS: LLR significantly reduced time to oral intake, hospital stay, and incisional hernias compared to OS.
  • Bleeding is a major risk and should be carefully considered when resecting benign tumors.
  • In the hands of expert surgeons, LLR may become the gold standard for the resection of benign liver tumors located in the anterior and lateral sectors and for minor hepatic resections.
  • [MeSH-major] Hepatectomy / methods. Laparoscopy / methods. Liver Neoplasms / pathology. Liver Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Case-Control Studies. Chi-Square Distribution. Female. Follow-Up Studies. Humans. Laparotomy / adverse effects. Laparotomy / methods. Length of Stay. Male. Middle Aged. Minimally Invasive Surgical Procedures / adverse effects. Minimally Invasive Surgical Procedures / methods. Neoplasm Staging. Pain, Postoperative / physiopathology. Probability. Retrospective Studies. Risk Assessment. Statistics, Nonparametric. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Surg. 1997 Nov-Dec;21(9):983-90; discussion 990-1 [9361515.001]
  • [Cites] Ann Surg. 1999 Apr;229(4):460-6 [10203077.001]
  • [Cites] Ann Chir. 2002 Mar;127(3):164-70 [11933628.001]
  • [Cites] Surg Endosc. 1998 Jan;12(1):76-8 [9419311.001]
  • [Cites] Gut. 1991 Jun;32(6):677-80 [2060877.001]
  • [Cites] Ann Surg. 1988 Nov;208(5):558-64 [3190282.001]
  • [Cites] Surgery. 2004 Oct;136(4):804-11 [15467665.001]
  • [Cites] Gut. 1991 May;32(5):524-7 [2040476.001]
  • [Cites] J Hepatol. 1993 Jul;18(3):276-8 [8228119.001]
  • [Cites] Br J Surg. 2007 Jan;94(1):58-63 [17054316.001]
  • [Cites] Surg Endosc. 2003 Dec;17(12):1914-8 [14574547.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):899-904 [12163951.001]
  • [Cites] Radiology. 1994 Nov;193(2):507-12 [7972769.001]
  • [Cites] Hepatogastroenterology. 1998 Nov-Dec;45(24):2333-8 [9951918.001]
  • [Cites] Cancer. 1991 Jul 15;68(2):341-7 [1712664.001]
  • [Cites] Surg Endosc. 2003 Jan;17(1):23-30 [12364994.001]
  • [Cites] Hum Pathol. 2005 Nov;36(11):1210-6 [16260275.001]
  • [Cites] Am Surg. 1996 Oct;62(10 ):825-9 [8813164.001]
  • [Cites] Lancet. 1980 Feb 9;1(8163):273-6 [6101735.001]
  • [Cites] Hepatology. 1995 Dec;22(6):1674-81 [7489973.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(2):242-8 [12140614.001]
  • [Cites] Hepatology. 2006 Dec;44(6):1694-700 [17133494.001]
  • [Cites] Br J Surg. 2006 Jan;93(1):67-72 [16273531.001]
  • [Cites] Surg Endosc. 1996 Jul;10(7):758-61 [8662435.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2005;12(5):351-5 [16258801.001]
  • [Cites] J Hepatol. 1996;25 Suppl 1:30-4 [8954189.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):13-8 [7740799.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):19-24 [7740805.001]
  • [Cites] J Clin Ultrasound. 1996 Sep;24(7):345-50 [8873856.001]
  • [Cites] Ann Surg. 2000 Dec;232(6):753-62 [11088070.001]
  • [Cites] Surgery. 2007 Feb;141(2):203-211 [17263977.001]
  • [Cites] Chirurg. 2002 May;73(5):474-80 [12089832.001]
  • [Cites] J Am Coll Surg. 2003 Feb;196(2):236-42 [12595052.001]
  • [Cites] Surg Gynecol Obstet. 1992 May;174(5):403-7 [1315081.001]
  • (PMID = 17705077.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Mohtasham N, Habibi A, Jafarzadeh H, Amirchaghmaghi M: Extension of Pindborg tumor to the maxillary sinus: a case report. J Oral Pathol Med; 2008 Jan;37(1):59-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extension of Pindborg tumor to the maxillary sinus: a case report.
  • The calcifying epithelial odontogenic tumor is a benign epithelial odontogenic lesion that accounts for less than 1% of all odontogenic tumors.
  • This tumor was encased between the right maxillary lateral and canine roots with extension to the maxillary sinus.
  • Histologically, the tumor is composed of sheets of epithelial cells with eosinophilic or clear cytoplasm, intercellular bridges, nuclear pleomorphism, but no mitotic figures, amorphous eosinophilic and calcified materials were seen within the sheets of epithelial cells.
  • [MeSH-major] Maxillary Neoplasms / pathology. Maxillary Sinus Neoplasms. Neoplasm Invasiveness. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18154580.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


16. Gopalakrishnan R, Simonton S, Rohrer MD, Koutlas IG: Cystic variant of calcifying epithelial odontogenic tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec;102(6):773-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic variant of calcifying epithelial odontogenic tumor.
  • Calcifying epithelial odontogenic tumor (CEOT) is a benign, locally aggressive odontogenic neoplasm characterized by sheets and nests of epithelial cells with deeply eosinophilic or occasionally clear cytoplasm, calcifications, and eosinophilic amorphous material that stains positive for amyloid.
  • [MeSH-major] Maxillary Neoplasms / pathology. Odontogenic Cyst, Calcifying / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Adolescent. Calcinosis / pathology. Humans. Male. Maxillary Sinus Neoplasms / pathology

  • Genetic Alliance. consumer health - Calcifying Epithelial Odontogenic Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17138180.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Pimenta FJ, Gontijo Silveira LF, Tavares GC, Silva AC, Perdigão PF, Castro WH, Gomez MV, Teh BT, De Marco L, Gomez RS: HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol; 2006 Aug;42(7):735-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ossifying fibroma (OF) is a benign neoplasm related to bone characterized by a progressive enlargement of the affected jaw.
  • Recently, the candidate tumor suppressor gene HRPT2 was identified and alterations in this gene were related with the Hyperparathyroidism-jaw tumor syndrome that is characterized by parathyroid adenoma or carcinoma, fibro-osseous lesions (mainly OF) of the jaws, and renal lesions.
  • Tumour and blood samples were obtained from 3 patients with OF and one with juvenile ossifying fibroma (JOF).
  • [MeSH-major] Fibroma, Ossifying / genetics. Genes, Tumor Suppressor. Mandibular Neoplasms / genetics. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Adolescent. Adult. Female. Gene Expression. Humans. Male. Middle Aged. Mutation. RNA, Messenger / genetics. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16458039.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDC73 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


18. Yepes JF, Mozaffari E, Ruprecht A: Case report: B-cell lymphoma of the maxillary sinus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec;102(6):792-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The radiographic manifestation of malignant lesions of the maxillary sinus on dental radiographs may be nonspecific, making it difficult to differentiate the lesion from disease of odontogenic origin or more benign sinus pathoses.
  • A radiopaque mass in the maxillary sinus, resulting from a malignant neoplasm growing within or extending into the sinus, can be easily confused with the mass of a mucous retention pseudocyst.
  • A case of B-cell lymphoma is reported.
  • Radiographic and clinical features that should be considered in establishing a differential diagnosis of malignant disease are discussed.
  • [MeSH-major] Lymphoma, B-Cell / pathology. Maxillary Neoplasms / pathology. Maxillary Sinus Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Mucocele / diagnosis. Radiography, Panoramic. Tomography, X-Ray Computed

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17138183.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Dangore-Khasbage S, Degwekar SS, Bhowate RR, Banode PJ, Bhake A, Choudhary MS, Lohe VK: Utility of color Doppler ultrasound in evaluating the status of cervical lymph nodes in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug;108(2):255-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Utility of color Doppler ultrasound in evaluating the status of cervical lymph nodes in oral cancer.
  • OBJECTIVE: The aim was to study the utility of color Doppler ultrasound (CDUS) in diagnosis of cervical lymphadenopathy in oral cancer patients.
  • STUDY DESIGN: In a prospective study, 70 cervical lymph nodes in 30 known primary oral cancer patients were evaluated with CDUS during a period of 8 months.
  • According to the CDUS, out of 70 nodes, 49 lymph nodes showed features of benign lymphadenopathy and 21 lymph nodes showed features of malignant lymphadenopathy, whereas histopathologic evaluations were in favor of reactive for 57 (81.42%) and for malignant lymphadenopathy in 13 (18.57%).
  • [MeSH-major] Lymph Nodes / ultrasonography. Lymphatic Metastasis / ultrasonography. Mouth Neoplasms / pathology. Ultrasonography, Doppler, Color
  • [MeSH-minor] Female. Humans. Lymphatic Diseases / pathology. Lymphatic Diseases / ultrasonography. Male. Neck. Neoplasm Staging / methods. Prospective Studies. Regional Blood Flow. Sensitivity and Specificity. Sentinel Lymph Node Biopsy. Statistics, Nonparametric

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19272807.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


20. Torres-Domingo S, Bagan JV, Jiménez Y, Poveda R, Murillo J, Díaz JM, Sanchis JM, Gavaldá C, Carbonell E: Benign tumors of the oral mucosa: a study of 300 patients. Med Oral Patol Oral Cir Bucal; 2008 Mar;13(3):E161-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign tumors of the oral mucosa: a study of 300 patients.
  • OBJECTIVES: To analyze the frequency and type of the most common benign tumors of the oral mucosa found at the Hospital Stomatology Service, and to study the clinical characteristics and possible etiological factors.
  • MATERIAL AND METHODS: This is a retrospective study of 300 patients with histologically diagnosed benign tumors of the oral mucosa.
  • Data was compiled for each case, documenting information relating to age, gender, medication, habits (smoking, oral hygiene), anamnesis (reason for consultation, symptomatology, evolution), and the characteristics of the lesion (site, color, size, surface, consistency, and base).
  • RESULTS: Of all the tumors studied, 53% were histologically diagnosed as fibroma.
  • In the study of prevalence of benign tumors of the oral mucosa, no differences were found for age; however there were differences according to gender, finding a greater prevalence of fibromas, pyogenic granulomas, and giant cell granulomas in women, at a ratio of 2:1.
  • The group of tumors studied showed a significantly asymptomatic behaviour, and self-limiting and slow growth.
  • CONCLUSIONS: Following the study of 300 patients histologically diagnosed with benign tumor of the oral mucosa, we can state that with regard to prevalence, we found significant differences with respect to gender, being more frequent in women.
  • The fibroma is the most frequent benign tumor of the oral cavity.
  • [MeSH-major] Mouth Mucosa. Mouth Neoplasms

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18305435.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


21. Chen WL, Yang ZH, Huang ZQ, Chai Q, Zhang DM: Facial contour reconstruction after benign tumor ablation using reverse facial-submental artery deepithelialized submental island flaps. J Craniofac Surg; 2010 Jan;21(1):83-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Facial contour reconstruction after benign tumor ablation using reverse facial-submental artery deepithelialized submental island flaps.
  • Reverse facial-submental artery deepithelialized submental island flaps were used for reconstructing facial contour deformities in 5 patients after benign tumor ablation.
  • The flap can be used reliably for facial contour reconstruction of middle and upper facial contour deformities after benign tumor ablation in the cheek and inferior temple.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Facial Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Surgical Flaps / blood supply
  • [MeSH-minor] Adult. Cheek. Female. Forehead. Humans. Male. Neoplasm Recurrence, Local / surgery. Postoperative Complications. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20061969.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Sugiyama T, Nakagawa T, Narita M, Nakamura S, Inui M, Tagawa T: Pedunculated oncocytic carcinoma in buccal mucosa: immunohistochemical and ultrastructural studies. Oral Dis; 2006 May;12(3):324-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An incision biopsy revealed the diagnosis of oncocytic tumor, and enucleation was performed.
  • The tumor was stained for immunohistochemical analysis using the ABC method and antibodies against cytokeratin (CK), epithelial membrane antigen (EMA), desmin, S-100 protein and muscle-specific actin, respectively.
  • The tumor was stained with uranyl acetate and lead citrate for visualization by electron microscopy.
  • RESULTS: Histopathology results revealed that the tumor consisted of oncocytic cells, characterized by eosinophilic and granular cytoplasm, and atypical nuclei.
  • Immunohistochemical staining indicated that these cells were positive for CK and EMA, and negative for desmin, muscle-specific actin and S-100 protein.
  • Electron microscopy revealed numerous dilated cytoplasmic mitochondria, and the cell contours and nucleic shapes of tumor cells were often irregular.
  • CONCLUSIONS: Because the histopathologic features of OC are similar to those of benign oncocytoma, the diagnosis of OC must be confirmed by a combination of clinical and ultrastructural characteristics.
  • [MeSH-major] Adenocarcinoma / pathology. Mouth Neoplasms / pathology
  • [MeSH-minor] Aged, 80 and over. Cheek / pathology. Humans. Immunohistochemistry. Keratins / analysis. Male. Microscopy, Electron, Transmission. Mitochondria / pathology. Mouth Mucosa / pathology. Mucin-1 / analysis. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16700744.001).
  • [ISSN] 1354-523X
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Mucin-1; 68238-35-7 / Keratins
  •  go-up   go-down


23. Kruse AL, Zwahlen RA, Grätz KW: New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years. Head Neck Oncol; 2009;1:31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The ameloblastic carcinoma is a rare malignant odontogenic tumor which rather occurs in the mandible than in the maxilla.
  • Current classifications do not consider benign histopathological features at the primary and malignant features at the metastatic tumour site.
  • In 54% the primary diagnosis was ameloblastic carcinoma, 34.6% revealed pulmonary metastases, however, only in one patient cervical lymph node metastasis could be found.
  • Nineteen of 26 patients (73,1%) were controlled during a median follow-up time of 54,3 months (6 to 156 months); 6 patients died of disease after a median time of 62,7 months (7 to 156 months) after initial diagnosis.
  • [MeSH-major] Ameloblastoma / classification. Maxillary Neoplasms / classification
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Evidence-Based Medicine. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 1993 Oct;51(10):1152-5; discussion 1156-7 [8410456.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):169-71 [8298419.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99 [7633291.001]
  • [Cites] J Laryngol Otol. 1995 Oct;109(10):1019-22 [7499939.001]
  • [Cites] Diagn Cytopathol. 1996 May;14(3):249-52 [8732656.001]
  • [Cites] J Oral Pathol Med. 1998 Jan;27(1):39-42 [9466734.001]
  • [Cites] J Craniomaxillofac Surg. 1998 Jun;26(3):159-62 [9702634.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):170-6 [10468461.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Sep;65(9):1800-3 [17719401.001]
  • [Cites] Ann Surg. 1948 Nov;128(5):999-1005 [17859260.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24 [17942338.001]
  • [Cites] Pediatr Blood Cancer. 2008 Jan;50(1):175-6 [16652346.001]
  • [Cites] Pathologe. 2008 May;29(3):214-20 [18330573.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jan;60(1):102-4 [11757019.001]
  • [Cites] J Craniomaxillofac Surg. 2002 Oct;30(5):273-9 [12377199.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Jun;61(6):731-4 [12796889.001]
  • [Cites] Oral Oncol. 2003 Oct;39(7):736-41 [12907214.001]
  • [Cites] J Can Dent Assoc. 2003 Oct;69(9):573-6 [14653932.001]
  • [Cites] J Craniofac Surg. 2004 Mar;15(2):264-9 [15167247.001]
  • [Cites] Laryngoscope. 2004 Oct;114(10):1770-4 [15454770.001]
  • [Cites] Bull Tokyo Dent Coll. 1972 May;13(2):91-101 [4504978.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1979 Feb 9;381(2):211-22 [154765.001]
  • [Cites] J Oral Surg. 1980 Mar;38(3):203-6 [6928185.001]
  • [Cites] Am J Clin Pathol. 1981 Apr;75(4):585-91 [7223720.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1982 Sep;54(3):299-303 [6957827.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1983 Sep-Oct;92(5 Pt 1):532 [6625456.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Feb;57(2):168-76 [6366686.001]
  • [Cites] J Oral Med. 1986 Apr-Jun;41(2):79-81 [3459830.001]
  • [Cites] J Maxillofac Surg. 1986 Dec;14(6):338-40 [3467002.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Nov;64(5):570-6 [3313152.001]
  • [Cites] Am J Clin Pathol. 1988 Oct;90(4):474-81 [3052019.001]
  • [Cites] J Otolaryngol. 1989 Apr;18(3):109-11 [2716084.001]
  • [Cites] J Craniomaxillofac Surg. 1990 Aug;18(6):247-50 [2212021.001]
  • (PMID = 19674470.001).
  • [ISSN] 1758-3284
  • [Journal-full-title] Head & neck oncology
  • [ISO-abbreviation] Head Neck Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2733136
  • [General-notes] NLM/ Original DateCompleted: 20100629
  •  go-up   go-down


24. Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA: CXCL5 promotes prostate cancer progression. Neoplasia; 2008 Mar;10(3):244-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The current study was intended to determine which of these cell types express CXCL5 in normal and malignant human prostatic tissues, whether expression levels correlated with malignancy and whether CXCL5 stimulated biologic effects consistent with a benign or malignant prostate epithelial phenotype.
  • The results of these studies show that CXCL5 protein expression levels are concordant with prostate tumor progression, are highly associated with inflammatory infiltrate, and are frequently detected in the lumens of both benign and malignant prostate glands.
  • These findings suggest that the inflammatory mediator, CXCL5, may play multiple roles in the etiology of both benign and malignant proliferative diseases in the prostate.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Genet Cytogenet. 2004 Oct 1;154(1):36-43 [15381370.001]
  • [Cites] J Cancer Res Clin Oncol. 2007 Nov;133(11):835-40 [17479287.001]
  • [Cites] Cancer Res. 1983 Apr;43(4):1809-18 [6831420.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 1995 Jan;31(1):14-24 [7535634.001]
  • [Cites] J Leukoc Biol. 1997 Nov;62(5):604-11 [9365115.001]
  • [Cites] Mol Cell Biol. 1998 Apr;18(4):2272-81 [9528798.001]
  • [Cites] Am J Pathol. 1999 May;154(5):1503-12 [10329603.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 1999 Jul-Aug;35(7):403-9 [10462204.001]
  • [Cites] Prostate. 1999 Oct 1;41(2):78-88 [10477904.001]
  • [Cites] Lab Invest. 2004 Dec;84(12):1666-76 [15467730.001]
  • [Cites] Arthritis Rheum. 2005 Mar;52(3):710-21 [15751074.001]
  • [Cites] Clin Cancer Res. 2005 Jun 1;11(11):4117-27 [15930347.001]
  • [Cites] Carcinogenesis. 2005 Jul;26(7):1170-81 [15498784.001]
  • [Cites] J Immunol. 2005 Oct 15;175(8):5351-7 [16210641.001]
  • [Cites] Aging Cell. 2005 Dec;4(6):291-8 [16300481.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Feb;45(2):136-46 [16235240.001]
  • [Cites] BJU Int. 1999 Dec;84(9):976-81 [10571623.001]
  • [Cites] Am J Pathol. 1999 Dec;155(6):1985-92 [10595928.001]
  • [Cites] Urology. 2000 Nov 1;56(5):828-32 [11068311.001]
  • [Cites] Cancer Res. 2002 Mar 15;62(6):1832-7 [11912162.001]
  • [Cites] J Urol. 2002 May;167(5):2267-70 [11956490.001]
  • [Cites] Tumour Biol. 2002 Mar-Apr;23(2):93-102 [12065847.001]
  • [Cites] J Biol Chem. 2003 Nov 21;278(47):47038-45 [12970366.001]
  • [Cites] Gene. 2004 Jan 7;324:1-14 [14693367.001]
  • [Cites] Fertil Steril. 2004 Feb;81(2):305-8 [14967364.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63 [15240098.001]
  • [Cites] FASEB J. 2004 Aug;18(11):1240-2 [15180966.001]
  • [Cites] Genome Res. 2006 Feb;16(2):197-207 [16365378.001]
  • [Cites] Oral Oncol. 2006 Mar;42(3):240-56 [16266819.001]
  • [Cites] Cancer Res. 2006 Apr 15;66(8):4279-84 [16618752.001]
  • [Cites] Cancer Sci. 2006 Aug;97(8):697-702 [16800820.001]
  • [Cites] Prostate. 2006 Dec 1;66(16):1721-8 [16941672.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Oncogene. 2007 Mar 22;26(13):1971-82 [17043662.001]
  • [Cites] J Biol Chem. 2007 Sep 14;282(37):26767-74 [17631494.001]
  • [Cites] Invest Urol. 1979 Jul;17(1):16-23 [447482.001]
  • (PMID = 18320069.001).
  • [ISSN] 1476-5586
  • [Journal-full-title] Neoplasia (New York, N.Y.)
  • [ISO-abbreviation] Neoplasia
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA046592; United States / NIDDK NIH HHS / DK / P50 DK065313; United States / NCI NIH HHS / CA / 5 P30 CA46592; United States / NCI NIH HHS / CA / 5 P50 CA068568
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CXCL5 protein, human; 0 / Chemokine CXCL5; 0 / EGR1 protein, human; 0 / Early Growth Response Protein 1; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.24 / Mitogen-Activated Protein Kinases
  • [Other-IDs] NLM/ PMC2262133
  •  go-up   go-down


25. Abbas F, Memon A, Siddiqui T, Kayani N, Ahmad NA: Granular cell tumors of the urinary bladder. World J Surg Oncol; 2007;5:33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumors of the urinary bladder.
  • BACKGROUND: Granular cell tumors (GCTs) are extremely rare lesions of the urinary bladder with only nine cases being reported in world literature of which one was malignant.
  • Generally believed to be of neural origin based on histochemical, immunohistochemical, and ultrastructural studies; they mostly follow a clinically benign course but are commonly mistaken for malignant tumors since they are solid looking, ulcerated tumors with ill-defined margins.
  • MATERIALS AND METHODS: We herein report two cases of GCTs, one benign and one malignant, presenting with gross hematuria in a 14- and a 47-year-old female, respectively.
  • RESULTS: Histopathology revealed characteristic GCTs with positive immunostaining for neural marker (S-100) and negative immunostaining for epithelial (cytokeratin, Cam 5.2, AE/A13), neuroendocrine (neuron specific enolase, chromogranin A, and synaptophysin) and sarcoma (desmin, vimentin) markers.
  • The benign tumor was successfully managed conservatively with transurethral resection alone while for the malignant tumor, radical cystectomy, hysterectomy with bilateral salpingo-oophorectomy, anterior vaginectomy, plus lymph node dissection was done.
  • CONCLUSION: We recommend careful pathologic assessment for establishing the appropriate diagnosis and either a conservative or aggressive surgical treatment for benign or localized malignant GCT of the urinary bladder, respectively.
  • [MeSH-major] Cystoscopy / methods. Granular Cell Tumor / pathology. Granular Cell Tumor / surgery. Neoplasm Invasiveness / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adolescent. Biopsy, Needle. Emergency Service, Hospital. Female. Follow-Up Studies. Hematuria / diagnosis. Hematuria / etiology. Humans. Immunohistochemistry. Middle Aged. Neoplasm Staging. Nephrostomy, Percutaneous / methods. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pathol. 1973 Feb;109(2):101-11 [4124410.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1963 Oct;16:1202-13 [14079990.001]
  • [Cites] Br J Urol. 1961 Mar;33:76-9 [13683165.001]
  • [Cites] J Laryngol Otol. 1998 Apr;112(4):373-6 [9659502.001]
  • [Cites] Am J Surg Pathol. 1991 Jan;15(1):48-58 [1985501.001]
  • [Cites] Br J Urol. 1985 Feb;57(1):109-10 [2982445.001]
  • [Cites] J Pathol. 1984 Mar;142(3):221-9 [6323661.001]
  • [Cites] Am J Pathol. 1983 Aug;112(2):139-46 [6192721.001]
  • [Cites] Cancer. 1982 Apr 15;49(8):1624-8 [6175391.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1980;386(2):239-48 [7189308.001]
  • [Cites] J Urol. 1974 Sep;112(3):343-5 [4368755.001]
  • [Cites] Cancer. 1962 Sep-Oct;15:936-54 [13893237.001]
  • [Cites] Am J Clin Pathol. 1971 Dec;56(6):736-49 [4108241.001]
  • [Cites] Cancer. 1971 Apr;27(4):948-55 [4102365.001]
  • [Cites] Hinyokika Kiyo. 1969 Jul;15(7):505-13 [4310526.001]
  • [Cites] J Urol. 1968 Dec;100(6):735-7 [4301412.001]
  • [Cites] Int J Urol. 2001 Jan;8(1):29-31 [11168695.001]
  • [Cites] BJU Int. 1999 Nov;84(7):871-2 [10532990.001]
  • (PMID = 17355632.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1828733
  • [General-notes] NLM/ Original DateCompleted: 20070810
  •  go-up   go-down


26. Aytac-Yazicioglu D, Eren H, Görgün S: Peripheral odontogenic myxoma located on the maxillary gingiva: report of a case and review of the literature. Oral Maxillofac Surg; 2008 Sep;12(3):167-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Odontogenic myxoma is a rare, benign neoplasm and is often located in the maxillofacial region centrally most common in the mandible.
  • [MeSH-major] Gingival Neoplasms / pathology. Myxoma / pathology. Odontogenic Tumors / pathology

  • Genetic Alliance. consumer health - Odontogenic myxoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diagn Cytopathol. 2002 Aug;27(2):111-4 [12203879.001]
  • [Cites] Head Neck Surg. 1985 Jul-Aug;7(6):479-83 [4044268.001]
  • [Cites] J Periodontol. 2001 Aug;72(8):1100-2 [11525444.001]
  • [Cites] Chang Gung Med J. 2001 Dec;24(12):826-31 [11858401.001]
  • [Cites] J Laryngol Otol. 2000 Jul;114(7):533-5 [10992937.001]
  • [Cites] J Oral Surg. 1971 Jan;29(1):41-4 [5276349.001]
  • [Cites] J Oral Surg. 1975 May;33(5):356-9 [1055192.001]
  • [Cites] J Oral Surg. 1969 Jan;27(1):32-5 [5248071.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1958 Oct;11(10):1069-80 [13590722.001]
  • [Cites] Tumori. 1980 Oct 31;66(5):655-9 [7466928.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1954 Oct;7(10):1091-1107 [13203953.001]
  • [Cites] Am J Clin Pathol. 1985 Sep;84(3):265-72 [4036856.001]
  • [Cites] J Am Acad Dermatol. 1990 Feb;22(2 Pt 2):343-5 [2303591.001]
  • [Cites] J Clin Periodontol. 2006 Jan;33(1):76-8 [16367860.001]
  • [Cites] J Oral Sci. 2000 Jun;42(2):107-9 [10989594.001]
  • [Cites] J Oral Pathol. 1977 Nov;6(6):343-58 [412928.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1978 Feb;45(2):246-54 [272605.001]
  • [Cites] J Oral Maxillofac Surg. 1993 Mar;51(3):269-73; discussion 274 [8445469.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Oct;59(10):1226-8 [11573188.001]
  • [Cites] J Maxillofac Surg. 1978 Nov;6(4):281-6 [282391.001]
  • [Cites] Arch Otolaryngol. 1976 May;102(5):300-5 [1267724.001]
  • [Cites] J Oral Surg. 1978 Aug;36(8):610-5 [277654.001]
  • [Cites] J Nihon Univ Sch Dent. 1985 Jun;27(2):119-25 [2931504.001]
  • [Cites] J Oral Maxillofac Surg. 1988 Aug;46(8):705-9 [3294359.001]
  • [Cites] Br J Oral Surg. 1975 Jul;13(1):95-7 [1056798.001]
  • [Cites] Ann Surg. 1948 May;127(4):706-19 [18917127.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1962 Mar;15:355-61 [14489722.001]
  • [Cites] J Maxillofac Surg. 1986 Feb;14 (1):46-52 [3456413.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1966 Jan;96(1):19-24 [5900878.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1953 Aug;6(8):927-36 [13087986.001]
  • (PMID = 18642035.001).
  • [ISSN] 1865-1550
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 39
  •  go-up   go-down


27. Maruya S, Shirasaki T, Nagaki T, Kakehata S, Kurotaki H, Mizukami H, Shinkawa H: Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications. BMC Cancer; 2009;9:72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of this study was to evaluate the expression of topoIIalpha in various types of salivary gland tumors and its biological significance.
  • METHODS: The protein expression of topoIIalpha was evaluated immunohistochemically in formalin-fixed, paraffin-embedded tissue from 54 salivary gland carcinomas and 20 benign tumors (10 pleomorphic adenomas and 10 Warthin's tumors).
  • RESULTS: Of the 54 primary salivary gland carcinomas, 38 (70%) showed positive expression (> or = 10%) of topoIIalpha protein, and 16 carcinomas (30%) and all benign tumors were negative (p < 0.001).
  • [MeSH-major] Antigens, Neoplasm / biosynthesis. DNA Topoisomerases, Type II / biosynthesis. DNA-Binding Proteins / biosynthesis. Salivary Gland Neoplasms / enzymology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 2000 Aug;22(5):489-97 [10897109.001]
  • [Cites] Head Neck. 2008 May;30(5):680-3 [17972317.001]
  • [Cites] Clin Cancer Res. 2002 Apr;8(4):1061-7 [11948114.001]
  • [Cites] Clin Cancer Res. 2002 May;8(5):1107-16 [12006526.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40 [12042765.001]
  • [Cites] Lancet Oncol. 2002 Apr;3(4):235-43 [12067686.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2003 Jan-Feb;65(1):26-32 [12624503.001]
  • [Cites] Am J Clin Pathol. 2003 May;119(5):715-22 [12760291.001]
  • [Cites] Clin Cancer Res. 2003 Oct 15;9(13):4682-8 [14581337.001]
  • [Cites] Int J Oncol. 2004 Jan;24(1):201-9 [14654958.001]
  • [Cites] Anticancer Res. 2003 Sep-Oct;23(5A):3965-70 [14666704.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):944-6 [14871971.001]
  • [Cites] J Otolaryngol. 2003 Oct;32(5):328-31 [14974865.001]
  • [Cites] Mod Pathol. 2004 Jun;17(6):637-45 [15044918.001]
  • [Cites] Arch Otolaryngol. 1984 Mar;110(3):172-6 [6322732.001]
  • [Cites] Cancer. 1984 Sep 15;54(6):1062-9 [6088017.001]
  • [Cites] Oncology (Williston Park). 1998 May;12(5):671-80; discussion 683 [9597678.001]
  • [Cites] Pathol Res Pract. 2005;200(11-12):791-9 [15792122.001]
  • [Cites] Breast Cancer Res. 2005;7(3):R374-84 [15987433.001]
  • [Cites] J Clin Oncol. 2006 Jun 10;24(17):2673-8 [16763282.001]
  • [Cites] Cancer Treat Rev. 2007 Feb;33(1):64-77 [17113234.001]
  • [Cites] Oral Oncol. 2007 Sep;43(8):735-41 [17113340.001]
  • [Cites] Head Neck. 2007 Nov;29(11):1002-9 [17427971.001]
  • [Cites] Hum Pathol. 2001 Jun;32(6):596-604 [11431714.001]
  • (PMID = 19250538.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / DNA-Binding Proteins; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha
  • [Other-IDs] NLM/ PMC2654461
  •  go-up   go-down


28. Jeblaoui Y, Ben Neji N, Haddad S, Ouertatani L, Hchicha S: [Algorithm for the treatment of ameloblastoma in Tunisia]. Rev Stomatol Chir Maxillofac; 2007 Nov;108(5):419-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Algorithme de prise en charge des améloblastomes en Tunisie.
  • INTRODUCTION: Ameloblastoma is a benign but locally aggressive and infiltrative odontogenic neoplasm.
  • Data with respect to the patients' ages, sex, tumor locations, and surgical treatment history, as well as radiographic findings and number of recurrences, was analyzed.
  • A radiographic assessment of the tumors showed that 85% were multicystic.
  • DISCUSSION: This study was characterized by the preponderance of the conservative treatment, the non-specification of histological types, systematic relapse, and the significant number of lost to follow-up.
  • [MeSH-major] Ameloblastoma / surgery. Mandibular Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Oral Surgical Procedures / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17572460.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


29. Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H: High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig; 2007 Mar;11(1):93-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies.
  • Tumour-invasion like wound healing is characterised by the formation of an extracellular matrix with a high tenascin-C content.
  • Analysis using antibody BC2 indicates that especially the high-molecular tenascin-C (hm tn-C) variants are typically tumour-associated, while distribution in normal tissue is restrictive.
  • This study investigated whether hm tn-C is a suitable indicator of atypical cells with invasive potential in oral brush biopsies.
  • One hundred fifty nine consecutive oral brush biopsies with histopathological diagnoses were analysed for the identification of atypical cells.
  • Conventional cytology produced four false-positives when identifying atypical cells in brush biopsies of inflammatory/benign hyperproliferative mucosa (specificity 96%), while 10 in 52 carcinomas and three of eight recurrences were not identified (sensitivity 78%).
  • Ten of these 13 non-identified tumours could be marked when adding the hm tn-C assay (increasing specificity to 99%).
  • The positive and negative predictive values were 92 and 88% for conventional cytology vs 98 and 97% for the dual assay. (1) A 95%-sensitivity proves hm tn-C assisted conventional cytology to be a suitable means of identifying atypical cells in oral brush biopsies. (2) The positive (98%) and negative (97%) predictive values obtained approximate hm tn-C assisted conventional cytology to laminin-5 (100/97%).
  • [MeSH-major] Biomarkers, Tumor / analysis. Biopsy / methods. Carcinoma, Squamous Cell / pathology. Mouth Neoplasms / pathology. Tenascin / analysis
  • [MeSH-minor] Epithelial Cells / pathology. Humans. Immunoenzyme Techniques. Mouth Mucosa / pathology. Neoplasm Invasiveness / pathology. Prospective Studies. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Cell Pathol. 2003;25(3):139-46 [12775918.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Jun;36(6):986-90 [15094113.001]
  • [Cites] Br J Cancer. 2006 Apr 24;94(8):1170-5 [16622441.001]
  • [Cites] Int J Mol Med. 2000 May;5(5):505-10 [10762653.001]
  • [Cites] Cancer. 2001 Sep 15;92(6):1419-26 [11745218.001]
  • [Cites] J Am Dent Assoc. 1999 Oct;130(10):1445-57 [10570588.001]
  • [Cites] J Oral Pathol Med. 2006 Sep;35(8):520; author reply 520-2 [16918607.001]
  • [Cites] Int J Cancer. 2002 Aug 20;100(6):719-22 [12209613.001]
  • [Cites] Int J Cancer. 1997 Jul 17;72(2):236-40 [9219826.001]
  • [Cites] Int J Cancer. 1992 Nov 11;52(5):688-92 [1385335.001]
  • [Cites] Oncology. 2003;64(3):245-50 [12697965.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Sep;96(3):252 [14515857.001]
  • [Cites] Anal Cell Pathol. 2001;22(4):211-21 [11564897.001]
  • [Cites] Biochem Cell Biol. 1997;75(6):759-69 [9599665.001]
  • [Cites] J Pathol. 2003 Jul;200(4):429-47 [12845611.001]
  • [Cites] J Pathol. 2004 Jul;203(3):771-9 [15221936.001]
  • [Cites] Int J Cancer. 1998 Mar 2;75(5):680-7 [9495234.001]
  • [Cites] Oral Oncol. 2004 Sep;40(8):824-8 [15288838.001]
  • [Cites] J Oral Pathol Med. 2006 Jan;35(1):58-60 [16393256.001]
  • [Cites] Cancer Res. 2002 Jun 1;62(11):3289-97 [12036947.001]
  • [Cites] Cytopathology. 2007 Dec;18(6):348-55 [18031447.001]
  • [Cites] J Oral Pathol Med. 1994 Nov;23(10):446-50 [7532219.001]
  • [Cites] J Oral Pathol Med. 2004 Aug;33(7):398-404 [15250831.001]
  • [Cites] Histochem Cell Biol. 2006 Jul;126(1):125-31 [16344911.001]
  • [Cites] Oral Oncol. 2004 Sep;40(8):829-34 [15288839.001]
  • [Cites] J Cancer Res Clin Oncol. 2001 May;127(5):286-92 [11355143.001]
  • [Cites] Oral Oncol. 2002 Jun;38(4):332-6 [12076695.001]
  • [Cites] J Pathol. 1999 Dec;189(4):475-80 [10629546.001]
  • [Cites] Gen Dent. 2002 Nov-Dec;50(6):500-3 [12572180.001]
  • [Cites] Mund Kiefer Gesichtschir. 2004 Jul;8(4):229-36 [15293118.001]
  • (PMID = 17111122.001).
  • [ISSN] 1432-6981
  • [Journal-full-title] Clinical oral investigations
  • [ISO-abbreviation] Clin Oral Investig
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Tenascin
  •  go-up   go-down


30. Roh JL, Ryu CH, Kim JS, Lee JS, Choi SH, Nam SY, Kim SY: Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer. Oral Oncol; 2007 Sep;43(8):757-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The accuracy of FDG PET and CT were drawn from patients in whom diagnosis was confirmed, by histopathology or follow-up imaging, and risk factors for thoracic malignancy were analyzed.
  • Most of the lesions (83%) with abnormal FDG uptake were benign, with thoracic malignancy confirmed in 15 patients (17%).
  • [MeSH-major] Head and Neck Neoplasms / pathology. Lung Neoplasms / radionuclide imaging. Lung Neoplasms / secondary. Mediastinal Neoplasms / radionuclide imaging. Mediastinal Neoplasms / secondary. Positron-Emission Tomography
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiography. Carcinoma, Squamous Cell / radionuclide imaging. Carcinoma, Squamous Cell / secondary. Female. Fluorodeoxyglucose F18. Humans. Image Interpretation, Computer-Assisted / methods. Male. Middle Aged. Neoplasm Staging. Radiopharmaceuticals. Retrospective Studies. Risk Factors. Sensitivity and Specificity. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17112773.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


31. Ritwik P, Brannon RB: Peripheral odontogenic fibroma: a clinicopathologic study of 151 cases and review of the literature with special emphasis on recurrence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep;110(3):357-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The peripheral odontogenic fibroma (POdF) is a rare benign neoplasm of odontogenic origin with limited data on recurrence.
  • RESULTS: POdF should be considered a mixed odontogenic tumor because it is composed of active odontogenic epithelial and ectomesenchymal components.
  • [MeSH-major] Fibroma / pathology. Jaw Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Child, Preschool. Follow-Up Studies. Humans. Infant. Infant, Newborn. Logistic Models. Male. Middle Aged. Mixed Tumor, Malignant / pathology. Sex Distribution. Time Factors. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20674403.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


32. Araújo VC, Demasi AP, Furuse C, Altemani A, Alves VA, Freitas LL, Araújo NS: Collagen type I may influence the expression of E-cadherin and beta-catenin in carcinoma ex-pleomorphic adenoma. Appl Immunohistochem Mol Morphol; 2009 Jul;17(4):312-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carcinoma ex-pleomorphic adenoma (CXPA) is an aggressive salivary gland malignancy, usually derived from a long-standing or a recurrent benign tumor, the pleomorphic adenoma (PA).
  • In the context of dynamic reciprocity, changes in the composition and structure of extracellular matrix proteins and cell surface receptors have been frequently associated with dysfunctional adhesion and invasive behavior of tumor cells.
  • By immunohistochemical analysis, we have demonstrated that direct contact of tumor cells with fibrillar type I collagen, particularly near the invasive front and in invasive areas prevailing small nests of CXPA cells, could be associated with reduced expression of the E-cadherin and beta-catenin adhesion molecules and with invasive behavior of epithelial, but not of CXPA with myoepithelial component.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19276972.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 0 / Collagen Type I; 0 / Neoplasm Proteins; 0 / beta Catenin
  •  go-up   go-down


33. Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF: Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone; 2008 Jan;42(1):68-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
  • BACKGROUND: Giant cell tumor (GCT) of bone is a benign but locally aggressive tumor that is characterized by the presence of mononuclear stromal cells and multinucleated giant cells.
  • Additional intravenous and oral bisphosphonates were given peri-operatively to 24 patients who were treated between 1998 and 2004.
  • CONCLUSION: Clinical use of bisphosphonates as an adjuvant therapy for giant cell tumor of bone demonstrated a lower local recurrence rate.
  • [MeSH-major] Bone Neoplasms. Diphosphonates / pharmacology. Extremities / pathology. Giant Cell Tumor of Bone. Neoplasm Recurrence, Local / prevention & control

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17962092.001).
  • [ISSN] 8756-3282
  • [Journal-full-title] Bone
  • [ISO-abbreviation] Bone
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Diphosphonates
  •  go-up   go-down


34. Lee SY, Chan WH, Sivanandan R, Lim DT, Wong WK: Recurrent giant fibrovascular polyp of the esophagus. World J Gastroenterol; 2009 Aug 7;15(29):3697-700
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Giant fibrovascular polyps of the esophagus and hypopharynx are rare benign esophageal tumors.
  • Even though they are benign, they may be lethal due to either bleeding or, rarely, asphyxiation if a large polyp is regurgitated.
  • The polyps may not be well visualized on endoscopy and imaging plays a vital role in aiding diagnosis as well as providing important information for pre-operative planning, such as the location of the pedicle, the vascularity of the polyp and the tissue elements of the mass.
  • We review the recent literature and report a case of a 61-year-old man with a recurrent giant esophageal fibrovascular polyp with illustrative contrast barium swallow, CT and intra-operative images, who required several surgeries via a combination of endoscopic, trans-oral, trans-cervical, trans-thoracic and trans-abdominal approaches.
  • [MeSH-major] Esophageal Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Polyps / surgery

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Esophagus. 2000;13(4):324-7 [11284984.001]
  • [Cites] Yonsei Med J. 2001 Apr;42(2):264-6 [11371118.001]
  • [Cites] Dig Dis Sci. 2002 Nov;47(11):2598-604 [12452402.001]
  • [Cites] Arch Pathol Lab Med. 2003 Apr;127(4):485-7 [12683881.001]
  • [Cites] AJR Am J Roentgenol. 1996 Apr;166(4):781-7 [8610549.001]
  • [Cites] Eur Radiol. 1998;8(2):264-9 [9477279.001]
  • [Cites] Am J Otolaryngol. 2007 Mar-Apr;28(2):115-7 [17362817.001]
  • [Cites] Abdom Imaging. 2005 Nov-Dec;30(6):653-5 [16132431.001]
  • [Cites] Ann Thorac Surg. 2006 Jan;81(1):393-6 [16368421.001]
  • [Cites] Eur Radiol. 2006 Mar;16(3):764-6 [16470418.001]
  • [Cites] Arch Pathol Lab Med. 2006 May;130(5):725-7 [16683893.001]
  • [Cites] J Korean Med Sci. 2006 Aug;21(4):749-51 [16891825.001]
  • [Cites] Abdom Imaging. 1999 Mar-Apr;24(2):109-10 [10024391.001]
  • (PMID = 19653354.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 13
  • [Other-IDs] NLM/ PMC2721250
  •  go-up   go-down


35. Zhang H, Feng Y, Jiang L: [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun;24(12):556-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)].
  • OBJECTIVE: To discuss the feasibility of tumorectomy by transoral approach of macrosis benign neoplasms in parapharyngeal space.
  • METHOD: Retrospective analyze 6 patients of macrosis benign neoplasms in parapharyngeal space from January 2005 to May 2008, and all neoplasms were removed by transoral approach.
  • RESULT: The neoplasms were all removed completely and successfully, and postoperative recovery were good and no complications were found.
  • CONCLUSION: Preoperative imaging examination is very important for diagnosis and treatment of benign neoplasm in parapharyngeal space, which is especially helpful to understand the scope of the tumor, and the relationship with carotid artery and vein.
  • On this basis, it is feasible to select the appropriate cases to resect huge benign neoplasm in parapharyngeal space.
  • [MeSH-major] Neoplasms / surgery. Oropharynx / surgery. Otorhinolaryngologic Surgical Procedures / methods. Pharyngeal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20806862.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


36. Brazão-Silva MT, Fernandes AV, Durighetto-Júnior AF, Cardoso SV, Loyola AM: Central odontogenic fibroma: a case report with long-term follow-up. Head Face Med; 2010;6:20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An osteolytic tumour of the mandible with prominent expansive growth on the alveolar ridge and displacement of the involved teeth is described in a 28-year-old man.
  • The lesion was diagnosed as a central odontogenic fibroma, an uncommon benign neoplasm derived from dental apparatus, and was removed by curettage.
  • [MeSH-major] Fibroma / surgery. Gingival Neoplasms / surgery. Odontogenic Tumors / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Diagn Pathol. 1999 Nov;16(4):293-6 [10587271.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):295-300 [15356466.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1980 Aug;50(2):140-5 [6930613.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1983 Jul;56(1):61-70 [6576312.001]
  • [Cites] J Oral Maxillofac Surg. 1991 Jan;49(1):46-54 [1702150.001]
  • [Cites] J Oral Pathol Med. 1991 Apr;20(4):149-58 [2061853.001]
  • [Cites] East Afr Med J. 1991 Mar;68(3):155-63 [2070750.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1994 Dec;78(6):811-8 [7898916.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Oct;82(4):426-33 [8899782.001]
  • [Cites] J Oral Pathol Med. 1996 Nov;25(10):556-61 [8986968.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2005;10 Suppl 2:E154-7 [15995576.001]
  • [Cites] J Oral Pathol Med. 2005 Nov;34(10):588-95 [16202078.001]
  • [Cites] Head Face Med. 2005;1:3 [16270916.001]
  • [Cites] J Oral Sci. 2005 Sep;47(3):149-57 [16313094.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jan;101(1):82-94 [16360612.001]
  • [Cites] Minerva Stomatol. 2006 Apr;55(4):229-39 [16618998.001]
  • [Cites] J Oral Pathol Med. 2006 Aug;35(7):385-91 [16827840.001]
  • [Cites] J Oral Pathol Med. 2006 Sep;35(8):513-6 [16918604.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul;104(1):101-9 [17507265.001]
  • [Cites] Oral Oncol. 2008 Jun;44(6):601-7 [17996487.001]
  • [Cites] Clinics (Sao Paulo). 2009;64(2):149-52 [19219321.001]
  • [Cites] Head Face Med. 2009;5:25 [19930688.001]
  • [Cites] Head Neck Pathol. 2009 Mar;3(1):51-3 [20596990.001]
  • [Cites] Periodontal Clin Investig. 2002 Fall;24(1):27-30 [12400730.001]
  • (PMID = 20707924.001).
  • [ISSN] 1746-160X
  • [Journal-full-title] Head & face medicine
  • [ISO-abbreviation] Head Face Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2927520
  •  go-up   go-down


37. Vanoven BJ, Parker NP, Petruzzelli GJ: Peripheral ameloblastoma of the maxilla: a case report and literature review. Am J Otolaryngol; 2008 Sep-Oct;29(5):357-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Peripheral ameloblastoma is a rare, benign, extraosseous neoplasm of the odontogenic epithelium.
  • We report a case of peripheral ameloblastoma, detail our surgical therapy and review important elements in the pathological diagnosis and treatment of this unusual neoplasm.
  • [MeSH-major] Ameloblastoma / pathology. Ameloblastoma / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery
  • [MeSH-minor] Aged. Biopsy, Needle. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Staging. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18722894.001).
  • [ISSN] 1532-818X
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 23
  •  go-up   go-down


38. Siar CH, Nakano K, Han PP, Nagatsuka H, Ng KH, Kawakami T: Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma. J Oral Pathol Med; 2010 Aug 1;39(7):552-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ameloblastoma, a benign odontogenic epithelial neoplasm, histologically recapitulates the enamel organ at bell stage.
  • RESULTS: Ameloblastoma tumor epithelium demonstrated positive expression for Notch1 (n = 5/10), Notch3 (n = 8/10), Notch4 (n = 10/10), Jagged1 (n = 6/10) and Delta1 (n = 5/10), but no reactivity for Notch2 (n = 10/10) and Jagged2 (10/10).
  • Stromal components namely endothelial cells and fibroblasts showed overexpression for Notch4 but were mildly or non-reactive for the other Notch members and their ligands.
  • CONCLUSIONS: These findings suggest that Notch receptors and their ligands may play differing roles during the development of the desmoplastic ameloblastoma with Notch4 probably playing a greater role in the acquisition of tissue-specific cellular characteristics in the desmoplastic ameloblastoma.
  • [MeSH-minor] Adult. Calcium-Binding Proteins / analysis. Cell Membrane / ultrastructure. Cell Nucleus / ultrastructure. Cytoplasm / ultrastructure. Endothelial Cells / pathology. Epithelial Cells / pathology. Epithelium / pathology. Female. Fibroblasts / pathology. Gene Expression Regulation, Neoplastic / genetics. Humans. Immunohistochemistry. Intercellular Signaling Peptides and Proteins / analysis. Intracellular Signaling Peptides and Proteins. Ligands. Male. Mandibular Neoplasms / pathology. Maxillary Neoplasms / pathology. Membrane Proteins / analysis. Middle Aged. Proto-Oncogene Proteins / analysis. Receptor, Notch1 / analysis. Receptor, Notch2 / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20337864.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / JAG2 protein, human; 0 / Ligands; 0 / Membrane Proteins; 0 / NOTCH1 protein, human; 0 / NOTCH2 protein, human; 0 / NOTCH3 protein, human; 0 / NOTCH4 protein, human; 0 / Proto-Oncogene Proteins; 0 / Receptor, Notch1; 0 / Receptor, Notch2; 0 / Receptors, Notch; 0 / delta protein; 134324-36-0 / Serrate proteins
  •  go-up   go-down


39. Eguia A, Uribarri A, Gay Escoda C, Crovetto MA, Martínez-Conde R, Aguirre JM: Granular cell tumor: report of 8 intraoral cases. Med Oral Patol Oral Cir Bucal; 2006 Aug;11(5):E425-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor: report of 8 intraoral cases.
  • Granular cell tumor (GCT) is an uncommon neoplasm of controversial origin that can appear in any corporal localization, including the orofacial region.
  • Although aggressive and malignant variants of this neoplasm have been described, most of GCTs are benign.
  • In spite of the amount of research, the etiology of this neoplasm remains unclear and its histogenesis and its possible muscular, connective or neural origin has been broadly debated.
  • In this paper 8 oral cases are presented, corresponding to 5 women and 3 men, with a mean age of 36.1 years old and a mean time of evolution of the lesions of 8.3 months.
  • The main clinicopathologic and diagnostic features of this neoplasm are reviewed and discussed.
  • [MeSH-major] Granular Cell Tumor / pathology. Mouth Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Female. Gingival Neoplasms / pathology. Humans. Male. Middle Aged. Mouth Mucosa / pathology. Tongue Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16878061.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


40. Kanda H, Ishii K, Ogura Y, Imamura T, Kanai M, Arima K, Sugimura Y: Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. Int J Cancer; 2008 Jan 15;122(2):444-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Alpha-1 adrenoceptor antagonists are generally prescribed for benign prostate hyperplasia with lower urinary tract symptoms.
  • In vivo, oral administration of naftopidil to nude mice inhibited the growth of PC-3 tumors as compared to vehicle-treated controls.
  • [MeSH-major] Adrenergic alpha-1 Receptor Antagonists. G1 Phase / drug effects. Naphthalenes / pharmacology. Piperazines / pharmacology. Prostatic Neoplasms / drug therapy. Prostatic Neoplasms / metabolism
  • [MeSH-minor] Adrenergic alpha-Antagonists / pharmacology. Animals. Cell Line, Tumor. Cell Proliferation. Cell Separation. Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Cyclin-Dependent Kinase Inhibitor p27. Flow Cytometry. Humans. Intracellular Signaling Peptides and Proteins / metabolism. Male. Mice. Mice, Nude. Neoplasm Transplantation. Receptors, Adrenergic, alpha-1 / metabolism

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2007 Wiley-Liss, Inc.
  • (PMID = 17918159.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adrenergic alpha-1 Receptor Antagonists; 0 / Adrenergic alpha-Antagonists; 0 / CDKN1A protein, human; 0 / CDKN1B protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Intracellular Signaling Peptides and Proteins; 0 / Naphthalenes; 0 / Piperazines; 0 / Receptors, Adrenergic, alpha-1; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; R9PHW59SFN / naftopidil
  •  go-up   go-down


41. Singaraju S, Wanjari SP, Parwani RN: Odontogenic myxoma of the maxilla: A report of a rare case and review of the literature. J Oral Maxillofac Pathol; 2010 Jan;14(1):19-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Odontogenic myxoma represents an uncommon benign neoplasm comprising of 3-6% of all odontogenic tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):449-54 [9347513.001]
  • [Cites] J Oral Surg. 1978 Oct;36(10):771-8 [280645.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Sep;90(3):348-53 [10982957.001]
  • [Cites] Eur J Radiol. 2001 Jan;37(1):1-4 [11274831.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jun;60(6):704-8 [12022114.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Dec;61(12):1463-6 [14663812.001]
  • [Cites] Br J Oral Maxillofac Surg. 1994 Oct;32(5):298-302 [7999737.001]
  • [Cites] Br J Oral Surg. 1977 Jul;15(1):3-18 [268214.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Dec;86(6):707-14 [9868729.001]
  • [Cites] Mayo Clin Proc. 1977 Apr;52(4):249-53 [846224.001]
  • [Cites] Oral Maxillofac Surg Clin North Am. 2004 Aug;16(3):359-74 [18088737.001]
  • [Cites] J Oral Pathol Med. 1992 Oct;21(9):401-3 [1432734.001]
  • [Cites] Aust Dent J. 1990 Dec;35(6):518-22 [2090083.001]
  • [Cites] Int J Oral Surg. 1978 Jun;7(3):148-55 [99378.001]
  • (PMID = 21180454.001).
  • [ISSN] 1998-393X
  • [Journal-full-title] Journal of oral and maxillofacial pathology : JOMFP
  • [ISO-abbreviation] J Oral Maxillofac Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2995999
  • [Keywords] NOTNLM ; Odontogenic myxomas / fibromyxoma / odontogenic tumors
  •  go-up   go-down


42. Kim K, Velez I, Kaltman SI, Lopez E, Stern D: Odontogenic carcinoma differentiation into rhabdomyosarcoma: report of a rare case. Quintessence Int; 2009 Nov-Dec;40(10):837-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The histology and clinical features of this aggressive odontogenic neoplasm are described.
  • Within the English-language literature, only 2 cases are reported of an odontogenic tumor with muscle differentiation: a benign odontogenic tumor (ameloblastoma) with differentiation into a rhabdomyosarcoma and an odontogenic sarcoma with smooth-muscle differentiation.
  • The general practitioner should be aware that odontogenic lesions may be malignant, even though this is extremely rare, and all tissue removed from the oral cavity should be submitted for biopsy.
  • [MeSH-major] Gingival Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Odontogenic Tumors / pathology. Rhabdomyosarcoma / pathology
  • [MeSH-minor] Aged. Biopsy. Diagnosis, Differential. Follow-Up Studies. Gingival Diseases / diagnosis. Granuloma, Giant Cell / diagnosis. Granuloma, Pyogenic / diagnosis. Humans. Male. Maxillary Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19898715.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


43. Ntomouchtsis A, Karakinaris G, Poulolpoulos A, Kechagias N, Kittikidou K, Tsompanidou C, Vahtsevanos K, Antoniades K: Benign lip lesions. A 10-year retrospective study. Oral Maxillofac Surg; 2010 Jun;14(2):115-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign lip lesions. A 10-year retrospective study.
  • OBJECTIVES: This paper aims to present a retrospective analysis of a cohort of patients with benign lip lesions managed over the last decade at the Department of Maxillofacial Surgical Oncology of Theagenio Cancer Hospital of Thessaloniki.
  • It aims to highlight the substantial clinical and histological diversity of the lesions, as well as to present an epidemiological analysis for the specific cohort/population.
  • Of these, 280 were malignant and 116 benign.
  • RESULTS: Of the benign lesions, the commonest were haemangiomas (19.28%), actinic keratosis (17.14%), intradermal naevus (14.28%), fibroma (9.28%), papilloma (7.85%), mild and moderate dysplasia (7.85%) and mucocele (7.14%).
  • The group included 17 different histological types of benign lesions.
  • CONCLUSIONS: Benign lip lesions do not usually pose a problem for the clinician and their surgical management is straightforward.
  • Accurate auditing and detailed statistical analysis aid in disease prevention and help avoid errors in diagnosis and management.
  • [MeSH-major] Lip Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Fibroma / epidemiology. Follow-Up Studies. Greece / epidemiology. Hemangioma / epidemiology. Humans. Leukoplakia, Oral / epidemiology. Lip Diseases / epidemiology. Male. Middle Aged. Mucocele / epidemiology. Neoplasm Recurrence, Local / epidemiology. Nevus, Intradermal / epidemiology. Papilloma / epidemiology. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 1990 Jul-Aug;12(4):316-20 [2193904.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1986 Sep;62(3):284-91 [3462634.001]
  • [Cites] Int J Paediatr Dent. 2006 Jan;16(1):31-9 [16364090.001]
  • [Cites] Community Dent Oral Epidemiol. 1980 Feb;8(1):1-26 [6929240.001]
  • [Cites] J Clin Pediatr Dent. 2000 Winter;24(2):133-5 [11314322.001]
  • [Cites] Dent Clin North Am. 2005 Jan;49(1):223-40, x [15567370.001]
  • [Cites] Int J Paediatr Dent. 2005 Mar;15(2):89-97 [15790365.001]
  • [Cites] J Am Dent Assoc. 2004 Sep;135(9):1279-86 [15493392.001]
  • [Cites] Community Dent Oral Epidemiol. 1991 Jun;19(3):129-40 [1864064.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Oct;88(4):469-72 [10519757.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2005 Nov-Dec;10(5):376-87 [16264385.001]
  • [Cites] J Am Dent Assoc. 2008 May;139(5):587-90 [18451375.001]
  • (PMID = 20112123.001).
  • [ISSN] 1865-1569
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


44. Matsubayashi S, Yoshihara T: Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study. Eur Arch Otorhinolaryngol; 2007 Jul;264(7):789-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The proliferative activity of the tumor cells and the expression of tumor-associated genes and sex steroid hormone receptors were investigated immunohistochemically in ten cases of carcinoma ex pleomorphic adenoma (Ca-ex-PA) of the salivary glands.
  • These were analyzed in benign and malignant components separately, and then were compared with ten cases of the other malignant tumors [adenocarcinomas, not otherwise specified (ACN) and salivary duct carcinomas (SDC)] and ten cases of pleomorphic adenomas (PA).
  • (1) malignant component of Ca-ex-PA showed a higher incidence of PCNA and Ki67 than benign component of Ca-ex-PA.
  • A significant difference between benign component of Ca-ex-PA and PA was not observed. (2) A significant difference in the incidence of p53, c-erbB-2, EGFR overexpression was observed only between malignant component of Ca-ex-PA and benign component of Ca-ex-PA. (3) The incidence of PCNA, Ki67, p53, c-erbB-2 overexpression in malignant component of Ca-ex-PA showed the highest data among the four groups.
  • These results suggest that Ca-ex-PA acquired the particular biological behavior in contrast to the other salivary neoplasms in the long-standing process while PA undergoes malignant transformation.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Antibodies, Neoplasm / immunology. Biomarkers, Tumor / immunology. Carcinoma, Ductal / pathology. Salivary Gland Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Immunohistochemistry / methods. Ki-67 Antigen / immunology. Ki-67 Antigen / metabolism. Male. Middle Aged. Neoplasm Recurrence, Local / immunology. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / pathology. Proliferating Cell Nuclear Antigen / immunology. Proliferating Cell Nuclear Antigen / metabolism. Receptor, Epidermal Growth Factor / immunology. Receptor, Epidermal Growth Factor / metabolism. Receptor, ErbB-2 / immunology. Receptor, ErbB-2 / metabolism. Receptors, Androgen / immunology. Receptors, Androgen / metabolism. Receptors, Estrogen / immunology. Receptors, Estrogen / metabolism. Retrospective Studies. Tumor Suppressor Protein p53 / immunology. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Salivary gland adenoma, pleomorphic.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Pathol Med. 1997 May;26(5):217-23 [9178173.001]
  • [Cites] Am J Clin Pathol. 2003 Jun;119(6):801-6 [12817426.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1989;415(6):523-31 [2508310.001]
  • [Cites] Clin Otolaryngol Allied Sci. 1999 Feb;24(1):52-4 [10196649.001]
  • [Cites] Acta Otolaryngol. 1968 Dec;66(6):477-92 [4308066.001]
  • [Cites] J Pathol. 1994 Jan;172(1):35-44 [7931825.001]
  • [Cites] Pathol Int. 1998 Apr;48(4):265-72 [9648154.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):923-7 [1353853.001]
  • [Cites] Science. 1989 May 12;244(4905):707-12 [2470152.001]
  • [Cites] Acta Otolaryngol. 1994 Mar;114(2):218-22 [8203205.001]
  • [Cites] Anticancer Res. 1995 Nov-Dec;15(6B):2623-6 [8669836.001]
  • [Cites] Cancer. 1997 Jun 15;79(12):2314-9 [9191518.001]
  • [Cites] Cancer. 1977 Feb;39(2):388-96 [189890.001]
  • [Cites] J Oral Pathol Med. 1998 Oct;27(9):434-40 [9790097.001]
  • [Cites] Cancer. 1996 Jan 15;77(2):223-30 [8625227.001]
  • [Cites] Cancer. 1977 May;39(5):2209-30 [192443.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Oct;80(4):440-4 [8521108.001]
  • [Cites] Mod Pathol. 1998 Nov;11(11):1033-8 [9831198.001]
  • [Cites] Head Neck. 2001 Sep;23(9):705-12 [11505478.001]
  • [Cites] J Oral Pathol Med. 2002 Nov;31(10):590-7 [12406304.001]
  • [Cites] Acta Otolaryngol Suppl. 1964;188:SUPPL 191:1-99 [14156485.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2037-44 [7697591.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1994 Jan;77(1):36-40 [8108094.001]
  • [Cites] Cancer. 2001 Oct 25;93(5):344-50 [11668470.001]
  • [Cites] J Clin Pathol. 2003 Dec;56(12):914-8 [14645349.001]
  • [Cites] Int J Surg Pathol. 2005 Oct;13(4):337-42 [16273189.001]
  • [Cites] Int J Oncol. 2001 Oct;19(4):865-71 [11562768.001]
  • [Cites] Am J Surg Pathol. 2000 Apr;24(4):579-86 [10757407.001]
  • [Cites] Arch Otolaryngol. 1984 Mar;110(3):172-6 [6322732.001]
  • [Cites] Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232 [7612182.001]
  • [Cites] Hum Pathol. 2001 Jun;32(6):596-604 [11431714.001]
  • [Cites] Cancer. 1998 Feb 1;82(3):439-47 [9452259.001]
  • [Cites] J Clin Pathol. 1987 May;40(5):532-4 [3584505.001]
  • [Cites] Cancer Lett. 1998 Oct 23;132(1-2):91-7 [10397458.001]
  • (PMID = 17310348.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies, Neoplasm; 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Proliferating Cell Nuclear Antigen; 0 / Receptors, Androgen; 0 / Receptors, Estrogen; 0 / Tumor Suppressor Protein p53; EC 2.7.10.1 / EGFR protein, human; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


45. Hong KH, Yang YS: Intraoral approach for the treatment of submandibular salivary gland mixed tumors. Oral Oncol; 2008 May;44(5):491-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraoral approach for the treatment of submandibular salivary gland mixed tumors.
  • Pleomorphic adenoma represents a most common benign neoplasm of major salivary glands.
  • Most occurrences of this benign tumor in the submandibular gland have been treated surgically without difficulty via transcervical approach.
  • In this study, we introduced the intraoral approach for the removal of the submandibular mixed tumor.
  • During surgery the tumor and submandibular gland are easily dissected from surrounding tissue and removed through intraoral incision.
  • All patients were followed up for the recurrence of the tumor from 20 months to 10 years.
  • One patient showed a tumor recurrence at the early stage of this approach.
  • We propose that the benign mixed tumor of the submandibular gland could be removed easily via intraoral route without an external scar or nerve injury.
  • [MeSH-major] Adenoma, Pleomorphic / surgery. Postoperative Complications / prevention & control. Submandibular Gland / surgery. Submandibular Gland Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17827052.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


46. Veit AC, Painter JT, Miller RA, Hardisty JF, Dixon D: Characterization of uterine granular cell tumors in B6C3F1 mice: a histomorphologic, immunohistochemical, and ultrastructural study. Vet Pathol; 2008 Sep;45(5):654-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of uterine granular cell tumors in B6C3F1 mice: a histomorphologic, immunohistochemical, and ultrastructural study.
  • The granular cell tumor is most often a benign neoplasm of uncertain origin.
  • Four uterine granular cell tumors in control and treated female B6C3F1 mice were identified in chronic studies at the National Toxicology Program.
  • Two tumors occurred in untreated control animals and 2 in treated animals receiving different compounds.
  • Tissue sections were evaluated histologically and stained with hematoxylin and eosin, periodic acid-Schiff with diastase resistance, Masson's trichrome, toluidine blue, phosphotungstic acid-hematoxylin, and stained immunohistochemically with a panel of antibodies to muscle (desmin, alpha smooth muscle actin), neural (S-100, neuron specific enolase), epithelial (wide-spectrum cytokeratin), and macrophage (F4/80) markers.
  • The main histomorphologic feature of tumor cells was the presence of abundant cytoplasmic eosinophilic granules that stained positive for periodic acid-Schiff with diastase resistance.
  • Tumors varied in appearance and were comprised of sheets and nests of round to polygonal cells with distinct borders.
  • Tumors were pale pink and homogeneous with trichrome stain and negative with toluidine blue.
  • Three tumors had positive to weakly positive immunoreactivity for desmin, and 1 was positive for alpha smooth muscle actin.
  • Expression of S-100, wide-spectrum cytokeratin, and neuron-specific enolase was negative for all tumors.
  • The characteristics of these uterine granular cell tumors were suggestive of a myogenic origin.
  • [MeSH-major] Granular Cell Tumor / veterinary. Uterine Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pathol. 1984 Mar;142(3):221-9 [6323661.001]
  • [Cites] Cancer. 1984 May 15;53(10):2104-10 [6704900.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;406(1):1-5 [2581359.001]
  • [Cites] J Comp Pathol. 1985 Apr;95(2):175-92 [3915749.001]
  • [Cites] Vet Pathol. 1987 Jan;24(1):50-8 [3824823.001]
  • [Cites] Vet Pathol. 1987 May;24(3):273-6 [3603967.001]
  • [Cites] Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53(1):52-7 [2885972.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Apr;65(4):427-35 [2834681.001]
  • [Cites] J Comp Pathol. 1988 May;98(4):481-7 [3417916.001]
  • [Cites] Vet Pathol. 1984 Sep;21(5):489-94 [6091314.001]
  • [Cites] J Comp Pathol. 1989 Jul;101(1):109-12 [2794147.001]
  • [Cites] Crit Rev Toxicol. 1990;20(4):287-310 [2178628.001]
  • [Cites] Lab Anim. 1991 Oct;25(4):299-302 [1753688.001]
  • [Cites] Vet Pathol. 1992 Jan;29(1):86-9 [1557868.001]
  • [Cites] Vet Pathol. 1993 Mar;30(2):176-85 [8470338.001]
  • [Cites] Ultrastruct Pathol. 1993 May-Aug;17(3-4):271-8 [8266592.001]
  • [Cites] Toxicol Pathol. 1997 Mar-Apr;25(2):211-6 [9125780.001]
  • [Cites] Toxicol Pathol. 1997 Jul-Aug;25(4):409 [9280127.001]
  • [Cites] Adv Anat Pathol. 1999 Jul;6(4):186-203 [10410172.001]
  • [Cites] Arch Pathol Lab Med. 1999 Oct;123(10):967-73 [10506457.001]
  • [Cites] J Natl Cancer Inst. 1961 Sep;27:611-53 [13726967.001]
  • [Cites] J Natl Cancer Inst. 1963 Aug;31:425-55 [14046632.001]
  • [Cites] Vet Rec. 2006 Feb 4;158(5):168-70 [16461626.001]
  • [Cites] Vet Pathol. 2000 Sep;37(5):439-48 [11055867.001]
  • [Cites] J Vet Med Sci. 2001 Apr;63(4):449-52 [11346182.001]
  • [Cites] Vet Pathol. 2001 May;38(3):332-6 [11355666.001]
  • [Cites] Vet Pathol. 2001 Nov;38(6):620-7 [11732794.001]
  • [Cites] J Vet Med Sci. 2004 Jan;66(1):77-9 [14960817.001]
  • [Cites] Vet Clin Pathol. 2004;33(2):111-4 [15195271.001]
  • [Cites] Arch Pathol Lab Med. 2004 Jul;128(7):771-5 [15214825.001]
  • [Cites] Am J Vet Res. 1968 Jun;29(6):1309-13 [4297859.001]
  • [Cites] J Pathol. 1973 Feb;109(2):101-11 [4124410.001]
  • [Cites] Pathol Annu. 1974;9(0):43-79 [4371717.001]
  • [Cites] Cornell Vet. 1978 Oct;68(4):506-20 [213238.001]
  • [Cites] J Oral Surg. 1979 Jun;37(6):402-6 [220399.001]
  • [Cites] J Comp Pathol. 1979 Jul;89(3):421-30 [231057.001]
  • [Cites] Histopathology. 1981 Jan;5(1):69-79 [7194305.001]
  • [Cites] J Environ Pathol Toxicol. 1980 Nov;4(5-6):81-95 [7217862.001]
  • [Cites] J Comp Pathol. 1981 Oct;91(4):471-81 [6274928.001]
  • [Cites] Vet Pathol. 1982 Jan;19(1):23-9 [7072082.001]
  • [Cites] Diagn Histopathol. 1982 Jul-Sep;5(3):205-11 [6183084.001]
  • [Cites] J Oral Pathol. 1982;11(5):343-52 [6183416.001]
  • [Cites] Vet Q. 1983;5(2):89-93 [6308883.001]
  • [Cites] Am J Pathol. 1983 Aug;112(2):139-46 [6192721.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1983;402(1):35-45 [6318425.001]
  • (PMID = 18725470.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 ES999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS103826; NLM/ PMC2691646
  •  go-up   go-down


47. Levi PA Jr, Kim DM, Harsfield SL, Jacobson ER: Squamous cell carcinoma presenting as an endodontic-periodontic lesion. J Periodontol; 2005 Oct;76(10):1798-804
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Regardless of advances in diagnosis and treatment during the past 40 years, the overall 5-year survival rates for oral and oropharyngeal squamous cancers have only slightly improved and remain around 50%.
  • Thus, the early diagnosis and treatment of carcinoma by health care providers are essential in achieving a good prognosis.
  • We report a case of invasive squamous cell carcinoma that presented as a benign endodontic-periodontic lesion with a 7-mm periodontal pocket on tooth #15 in a 40-year-old, non-smoking woman.
  • METHODS: Our patient was seen for a comprehensive periodontal examination including a periodontal charting, occlusal analysis, study casts, electronic pulp test for tooth #15, and complete mouth periapical radiographs.
  • The patient remained free of tumor for 5 years after the initial presentation.
  • CONCLUSIONS: Patient education and periodic oral cancer examinations by dental professionals are necessary to reduce diagnostic delay and improve prognosis.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Gingival Neoplasms / pathology. Maxillary Neoplasms / pathology. Periodontal Cyst / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Maxillary Sinus Neoplasms / pathology. Neoplasm Invasiveness / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16253104.001).
  • [ISSN] 0022-3492
  • [Journal-full-title] Journal of periodontology
  • [ISO-abbreviation] J. Periodontol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Li G, Wu YT, Chen Y, Li TJ, Gao Y, Zhang J, Zhang ZY, Ma XC: Soft-tissue osteoma in the pterygomandibular space: report of a rare case. Dentomaxillofac Radiol; 2009 Jan;38(1):59-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoma is a slow-growing, benign and uncommon neoplasm located primarily in the region of the maxillofacial skeleton.
  • Clinical examination did not reveal any extraoral swelling, facial asymmetry or difficulty in mouth opening, and the regional lymph nodes were non-palpable.
  • Histological examination indicated the diagnosis of cancellous osteoma.
  • [MeSH-major] Head and Neck Neoplasms / radiography. Osteoma / radiography. Soft Tissue Neoplasms / radiography

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19114426.001).
  • [ISSN] 0250-832X
  • [Journal-full-title] Dento maxillo facial radiology
  • [ISO-abbreviation] Dentomaxillofac Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


49. Kuriakose MA, Trivedi NP, Kekatpure V: Anterior skull base surgery. Indian J Surg Oncol; 2010 Apr;1(2):133-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The basic principle of anterior skull base surgery is to provide adequate exposure to enable three dimensional resection of skull base tumors.
  • Negative surgical margins, which is within the control of surgeon, is the principle prognostic factor in anterior skull base tumors.
  • Open skull base approaches is the standard of care for malignant anterior skull base tumors.
  • Benign lesions may be resected by alternate minimally invasive approaches.
  • Advances in anterior skull base surgery, in particular the facial translocation approaches allows wide exposure of the tumors with minimal retraction of the brain.
  • The outcome of anterior skull base tumors have steadily increased over the years with disease free survival comparable to other malignant neoplasm of the head and neck region.
  • This review described various surgical approaches and pertaining anatomy and pathology of anterior skull base tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1979 Jul;89(7 Pt 1):1077-91 [449551.001]
  • [Cites] Arch Ophthalmol. 1977 Jul;95(7):1269-73 [880087.001]
  • [Cites] J Oral Maxillofac Surg. 1987 Jun;45(6):481-6 [3035154.001]
  • [Cites] Head Neck. 2000 Dec;22(8):772-80 [11084637.001]
  • [Cites] Head Neck. 2002 Mar;24(3):247-57 [11891956.001]
  • [Cites] Laryngoscope. 2002 Oct;112(10):1871-6 [12368633.001]
  • [Cites] Laryngoscope. 2002 Oct;112(10):1877-82 [12368634.001]
  • [Cites] Laryngoscope. 2002 Oct;112(10):1897-901 [12368639.001]
  • [Cites] Head Neck. 2002 Oct;24(10):901-11; discussion 912 [12369068.001]
  • [Cites] Head Neck. 2003 Jul;25(7):515-20 [12808653.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1993 Dec;119(12):1318-25 [17431985.001]
  • [Cites] Laryngoscope. 1988 Nov;98(11):1159-64 [3185068.001]
  • [Cites] Plast Reconstr Surg. 1985 Nov;76(5):695-702 [4059409.001]
  • [Cites] J Neurosurg. 1968 Apr;28(4):341-50 [5643926.001]
  • [Cites] Am J Surg. 1984 Oct;148(4):489-97 [6486318.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1995 Nov;121(11):1253-7 [7576471.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Nov;120(11):1203-8 [7917203.001]
  • [Cites] Head Neck. 1994 Jul-Aug;16(4):307-12 [8056574.001]
  • [Cites] Head Neck. 1994 Jan-Feb;16(1):3-10 [8125786.001]
  • [Cites] Otolaryngol Head Neck Surg. 1994 Jun;110(6):539-46 [8208569.001]
  • [Cites] J Craniofac Surg. 1993 Jul;4(3):142-7 [8241356.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1993 Apr;119(4):385-93 [8457302.001]
  • [Cites] Am J Otol. 1995 Jul;16(4):465-9 [8588646.001]
  • [Cites] Neurosurgery. 1996 Mar;38(3):471-9; discussion 479-80 [8837798.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Sep;17(8):1569-74 [8883658.001]
  • [Cites] Plast Reconstr Surg. 1996 Dec;98(7):1159-66; discussion 1167-8 [8942901.001]
  • [Cites] Br J Plast Surg. 1996 Dec;49(8):519-28 [8976743.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Mar;123(3):290-6 [9076235.001]
  • [Cites] Head Neck. 1997 Aug;19(5):391-9 [9243266.001]
  • [Cites] Am J Otolaryngol. 1997 Nov-Dec;18(6):431-3 [9395024.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Dec;123(12):1312-7 [9413360.001]
  • [Cites] Head Neck. 1998 May;20(3):193-6 [9570623.001]
  • [Cites] Head Neck. 1999 Jan;21(1):12-20 [9890346.001]
  • [Cites] Head Neck. 1999 Aug;21(5):402-7 [10402519.001]
  • [Cites] Am J Rhinol. 1999 Jul-Aug;13(4):303-10 [10485018.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):541-9 [10701732.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):396-401 [10722015.001]
  • [Cites] J Neurosurg. 2000 Oct;93(4):711-4 [11014555.001]
  • [Cites] Neurosurgery. 2000 Dec;47(6):1296-304; discussion 1304-5 [11126900.001]
  • [Cites] Neurosurgery. 2001 Jan;48(1):232-3; discussion 233-4 [11152355.001]
  • [Cites] Laryngoscope. 2001 Mar;111(3):483-7 [11224780.001]
  • [Cites] Plast Reconstr Surg. 2001 May;107(6):1346-55; discussion 1356-7 [11335798.001]
  • [Cites] Arch Facial Plast Surg. 2001 Apr-Jun;3(2):79-90 [11368657.001]
  • [Cites] Laryngoscope. 2001 Jul;111(7):1306-12 [11568560.001]
  • [Cites] Cancer. 2001 Dec 15;92(12):3012-29 [11753979.001]
  • [Cites] Br J Radiol. 2002 Apr;75(892):345-50 [12000693.001]
  • [Cites] Laryngoscope. 2002 Mar;112(3):424-7 [12148847.001]
  • [Cites] Plast Reconstr Surg. 2002 Oct;110(5):1303-9 [12360072.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Oct;128(10):1196-7 [12365893.001]
  • [Cites] Plast Reconstr Surg. 2003 Feb;111(2):568-74; discussion 575 [12560677.001]
  • [Cites] Laryngoscope. 2003 Mar;113(3):502-7 [12616204.001]
  • [Cites] Plast Reconstr Surg. 2003 Aug;112(2):703-4 [12900649.001]
  • [Cites] Cancer. 2003 Sep 15;98(6):1179-87 [12973841.001]
  • [Cites] Cancer. 1954 Sep;7(5):991-4 [13199776.001]
  • [Cites] Am J Surg. 1963 Nov;106:698-703 [14078719.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [14515089.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [14623748.001]
  • [Cites] Acta Neurochir (Wien). 2004 Jan;146(1):53-6; discussion 56-7 [14740265.001]
  • [Cites] Surg Oncol Clin N Am. 2004 Jan;13(1):167-86 [15062368.001]
  • [Cites] Laryngoscope. 2004 Mar;114(3):528-32 [15091229.001]
  • [Cites] Minim Invasive Neurosurg. 2004 Feb;47(1):1-8 [15100925.001]
  • [Cites] Acta Otorrinolaringol Esp. 2004 Jan;55(1):27-33 [15108619.001]
  • [Cites] Am J Otolaryngol. 2004 May-Jun;25(3):162-6 [15124164.001]
  • [Cites] Otolaryngol Head Neck Surg. 2004 Jun;130(6):780-7 [15195067.001]
  • [Cites] J Otolaryngol. 2004 Feb;33(1):32-6 [15291274.001]
  • [Cites] Otolaryngol Clin North Am. 2005 Feb;38(1):107-31, ix [15649503.001]
  • [Cites] Head Neck. 2005 Jun;27(6):445-51 [15825205.001]
  • [Cites] J Craniofac Surg. 2005 Nov;16(6):1085-91 [16327559.001]
  • (PMID = 22930628.001).
  • [ISSN] 0975-7651
  • [Journal-full-title] Indian journal of surgical oncology
  • [ISO-abbreviation] Indian J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3421004
  • [Keywords] NOTNLM ; Anterior skull base surgery / Craniofacial resection / Skull base reconstruction / Skull base surgery
  •  go-up   go-down


50. Yannopoulos P, Theodoridis P, Manes K: Esophagectomy without thoracotomy: 25 years of experience over 750 patients. Langenbecks Arch Surg; 2009 Jul;394(4):611-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: This is a retrospective analysis of all THE operations performed between January 1981 until May 2007 in 750 patients: 60 patients (8%) had benign lesions, while 690 (92%) had malignant ones (5.2% of malignancies were located in the upper esophagus, 7.4% in the middle esophagus, 19% in the lower esophagus, and 68.4% at the cardioesophageal junction).
  • We believe that our strategies concerning the way of dissecting the cervical esophagus, avoidance of performing pyloromyotomy, the delayed removal of the cervical drain and the delayed advance to oral feeding have reduced, noticeably, morbidity and mortality in our series.

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Surg. 2001 Feb;25(2):196-203 [11338022.001]
  • [Cites] Ann Surg. 2007 Sep;246(3):363-72; discussion 372-4 [17717440.001]
  • [Cites] Ann Thorac Surg. 2001 Dec;72(6):1918-24; discussion 1924-5 [11789772.001]
  • [Cites] Am J Surg. 2002 Feb;183(2):162-7 [11918882.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 2003 Apr;15(2):197-209 [12838490.001]
  • [Cites] Dis Esophagus. 2003;16(3):243-5 [14641318.001]
  • [Cites] Arch Surg. 2004 Jun;139(6):627-31; discussion 631-3 [15197089.001]
  • [Cites] Ann Thorac Surg. 2004 Oct;78(4):1170-6; discussion 1170-6 [15464465.001]
  • [Cites] Br J Surg. 1975 Aug;62(8):601-4 [1174797.001]
  • [Cites] J Thorac Cardiovasc Surg. 1978 Nov;76(5):643-54 [703369.001]
  • [Cites] Eur J Cardiothorac Surg. 1989;3(5):419-23; discussion 424 [2635923.001]
  • [Cites] Aust N Z J Surg. 1991 May;61(5):366-9 [2025191.001]
  • [Cites] Ann Surg. 1994 Sep;220(3):364-72; discussion 372-3 [8092902.001]
  • [Cites] J Surg Oncol. 1994 Nov;57(3):157-63 [7967604.001]
  • [Cites] Chest Surg Clin N Am. 1997 Aug;7(3):601-10; discussion 611-2 [9246405.001]
  • [Cites] J Thorac Cardiovasc Surg. 1997 Dec;114(6):948-55; discussion 955-6 [9434690.001]
  • [Cites] Surgery. 1999 Feb;125(2):142-7 [10026746.001]
  • [Cites] Ann Surg. 1999 Sep;230(3):392-400; discussion 400-3 [10493486.001]
  • [Cites] Surg Clin North Am. 2005 Jun;85(3):593-610 [15927654.001]
  • [Cites] Ann Thorac Surg. 2001 Jul;72(1):306-13 [11465217.001]
  • (PMID = 19350267.001).
  • [ISSN] 1435-2451
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC2687514
  •  go-up   go-down


51. Daskala I, Kalyvas D, Kolokoudias M, Vlachodimitropoulos D, Alexandridis C: Central odontogenic fibroma of the mandible: a case report. J Oral Sci; 2009 Sep;51(3):457-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Central odontogenic fibroma (COF) is a rare tumor that accounts for 0.1% of all odontogenic tumors.
  • It has been defined as a benign neoplasm, which appears in the jaw.
  • [MeSH-major] Mandibular Neoplasms / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Root Resorption / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19776515.001).
  • [ISSN] 1880-4926
  • [Journal-full-title] Journal of oral science
  • [ISO-abbreviation] J Oral Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


52. Maffini F, Fasani R, Petrella D, Maiorano E, Bruschini R, Pelosi G, Viale G: Sebaceous lymphadenoma of salivary gland: a case report and a review of the literature. Acta Otorhinolaryngol Ital; 2007 Jun;27(3):147-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The unusual case is described of a benign parotid gland neoplasm with intermingled sebaceous and lymphoid tissue, synchronous to breast cancer.
  • Secondary neoplasms have only occasionally been reported, since there are few cases for corroborating the strong correlation between salivary neoplasms and other carcinomas as in Muir-Torre syndrome; the previous cystic lesion showed the origin of the neoplasm from a sebaceous inclusion in the lymph node as a postulate of Warthin tumour.
  • [MeSH-major] Adenolymphoma / pathology. Salivary Gland Neoplasms / pathology. Sebaceous Gland Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Neoplasm Invasiveness / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1984 May 15;53(10):2155-70 [6704903.001]
  • [Cites] Am J Clin Pathol. 1980 Nov;74(5):683-7 [7446474.001]
  • [Cites] Zentralbl Allg Pathol. 1979;123(3):210-3 [473955.001]
  • [Cites] Indian J Pathol Bacteriol. 1975 Jan;18(1):46-8 [1132897.001]
  • [Cites] Arch Pathol. 1974 Nov;98(5):320-4 [4415696.001]
  • [Cites] Ala J Med Sci. 1973 Oct;10(4):453-4 [4791013.001]
  • [Cites] J Pathol. 1973 Jul;110(3):259-61 [4744068.001]
  • [Cites] Cancer. 1971 Oct;28(4):1019-22 [5111737.001]
  • [Cites] Ann Surg. 1969 Mar;169(3):437-43 [4314725.001]
  • [Cites] Am J Clin Pathol. 1970 Jan;53(1):100-3 [5410029.001]
  • [Cites] Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1966;187(3):836-44 [5985412.001]
  • [Cites] J Clin Pathol. 2004 Sep;57(9):1007 [15333672.001]
  • [Cites] Arch Otolaryngol. 1985 Apr;111(4):273-5 [3977760.001]
  • [Cites] Acta Cytol. 2004 Jul-Aug;48(4):551-4 [15296345.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Aug;32(4):423-6 [14505629.001]
  • [Cites] Ann Diagn Pathol. 2003 Aug;7(4):236-9 [12913846.001]
  • [Cites] HNO. 2003 May;51(5):417-20 [12841168.001]
  • [Cites] Histopathology. 2002 Oct;41(4):342-50 [12383217.001]
  • [Cites] J Oral Pathol Med. 2002 Apr;31(4):242-3 [12076329.001]
  • [Cites] J Oral Maxillofac Surg. 1999 Dec;57(12):1461-3 [10596670.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Nov;88(5):593-6 [10556755.001]
  • [Cites] Arch Pathol Lab Med. 1976 May;100(5):269-70 [946754.001]
  • [Cites] Cancer. 1960 Nov-Dec;13:1185-7 [13773927.001]
  • [Cites] Cancer. 1958 Nov-Dec;11(6):1156-79 [13608417.001]
  • [Cites] Beitr Pathol Anat. 1956;116(1):1-38 [13341851.001]
  • [Cites] Indian J Pathol Microbiol. 1994 Jul;37(3):327-30 [7814066.001]
  • [Cites] Pathol Res Pract. 1993 Jun;189(5):577-81; discussion 581-5 [8378181.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1994 Jan;77(1):19-26 [8108090.001]
  • (PMID = 17883194.001).
  • [ISSN] 0392-100X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 31
  • [Other-IDs] NLM/ PMC2640041
  •  go-up   go-down


53. Ettl T, Kleinheinz J, Mehrotra R, Schwarz S, Reichert TE, Driemel O: Infraorbital cutaneous angiosarcoma: a diagnostic and therapeutic dilemma. Head Face Med; 2008;4:18
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: A cutaneous angiosarcoma is a rare malignant tumour of vascular endothelial cells with aggressive clinical behaviour and poor prognosis.
  • Diagnosis is often delayed due to its variable and often benign clinical appearance.
  • Neither, finally achieved negative margins on permanent sections, nor a following chemotherapy could prevent the recurrence of the disease after five months and the patient's dead 21 months after the first diagnosis.
  • [MeSH-major] Facial Neoplasms / pathology. Hemangiosarcoma / pathology. Neoplasm Recurrence, Local / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Biopsy, Needle. Chemotherapy, Adjuvant. Combined Modality Therapy. Disease Progression. Fatal Outcome. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Reoperation

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2003 Nov 15;98(10):2251-6 [14601096.001]
  • [Cites] J Am Acad Dermatol. 2004 Jun;50(6):867-74 [15153886.001]
  • [Cites] Cancer. 1987 Mar 1;59(5):1046-57 [3815265.001]
  • [Cites] Am J Surg. 1990 Oct;160(4):365-9 [2221235.001]
  • [Cites] Am J Surg. 1994 Nov;168(5):451-4 [7977971.001]
  • [Cites] Cancer. 1995 Jul 15;76(2):319-27 [8625109.001]
  • [Cites] Cancer. 2003 Oct 15;98(8):1716-26 [14534889.001]
  • [Cites] Cancer. 2005 Jul 15;104(2):361-6 [15948172.001]
  • [Cites] Am J Clin Oncol. 2006 Oct;29(5):524-8 [17023791.001]
  • [Cites] Cancer. 1999 Nov 15;86(10):2034-7 [10570428.001]
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1061-6 [11474291.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2003 Sep;17(5):594-5 [12941106.001]
  • [Cites] J Am Acad Dermatol. 2003 Sep;49(3):530-1 [12963925.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2005 May;19(3):357-9 [15857466.001]
  • (PMID = 18694495.001).
  • [ISSN] 1746-160X
  • [Journal-full-title] Head & face medicine
  • [ISO-abbreviation] Head Face Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2533304
  •  go-up   go-down


54. Abiko Y, Nagayasu H, Takeshima M, Yamazaki M, Nishimura M, Kusano K, Kitajo H, Saitoh M, Kawakami T, Chiba I, Kaku T: Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of the p16 gene in malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan;103(1):72-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastic carcinoma meeting the WHO criteria may arise either as a result of malignant change in a pre-existing benign ameloblastoma (carcinoma ex ameloblastoma) or as a primary malignant ameloblastoma not preceded by an ordinary ameloblastoma (de novo carcinoma).
  • The DNA was extracted separately from benign and malignant areas in paraffin sections of the tumor.
  • Hypermethylation of CpG islands of the p16 gene was detected in the malignant parts of the tumor.
  • [MeSH-major] Ameloblastoma / genetics. Cell Transformation, Neoplastic / genetics. CpG Islands / genetics. DNA Methylation. Genes, p16. Mandibular Neoplasms / genetics
  • [MeSH-minor] Aged. Cadherins / analysis. DNA, Neoplasm / analysis. DNA-Binding Proteins / analysis. Genes, p53. Humans. Male

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17178497.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 0 / DNA, Neoplasm; 0 / DNA-Binding Proteins; 0 / PDRG1 protein, human
  •  go-up   go-down


55. Nazarian Y, Talmi YP, Wolf M, Horowitz Z, Bedrin L, Pfeffer R, Kronenberg J: [Recurrent pleomorphic adenomas of the parotid gland--treatment and outcome]. Harefuah; 2007 Feb;146(2):82-4, 168
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epithelial tumors of the parotid gland comprise 3% of head and neck tumors, and 70%-80% of those are benign.
  • Pleomorphic adenoma is the most common tumor of the parotid gland.
  • Recurrence rate of pleomorphic adenomas (RPAs) following superficial parotidectomy was reported to be as high as 4%, sometimes associated with inadequate surgical treatment of the primary tumor.
  • These tumors have a very slow growth rate, and a ten-year follow-up period is mandatory.
  • [MeSH-major] Adenoma / pathology. Neoplasm Recurrence, Local / pathology. Parotid Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17352271.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


56. Gümgüm S, Hoşgören B: Clinical and radiologic behaviour of ameloblastoma in 4 cases. J Can Dent Assoc; 2005 Jul-Aug;71(7):481-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastoma is a benign but locally aggressive epithelial odontogenic neoplasm.
  • We describe the clinical and radiologic behaviour of ameloblastoma and discuss treatment protocols and the possibility of conservative management of this tumour.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16026635.001).
  • [ISSN] 1488-2159
  • [Journal-full-title] Journal (Canadian Dental Association)
  • [ISO-abbreviation] J Can Dent Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


57. Eggers G, Mühling J, Hassfeld S: Inverted papilloma of paranasal sinuses. J Craniomaxillofac Surg; 2007 Jan;35(1):21-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Inverted papilloma (Schneiderian papilloma) is a primarily benign lesion that occurs in the nasal cavity and paranasal sinuses.
  • STUDY DESIGN: This is a review including a short introduction to the different histological types of nasal papilloma, their pathogenesis and the clinical and histopathological diagnosis.
  • A concept for the diagnosis, management, therapy and follow-up of inverted papilloma is proposed.
  • [MeSH-major] Papilloma, Inverted / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Cell Transformation, Neoplastic / pathology. Humans. Nasal Cavity / pathology. Neoplasm Recurrence, Local / pathology. Nose Neoplasms / pathology. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17267229.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 109
  •  go-up   go-down


58. Zhou CX, Gao Y: Oncocytoma of the salivary glands: a clinicopathologic and immunohistochemical study. Oral Oncol; 2009 Dec;45(12):e232-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a clinicopathologic and immunohistochemical study of 21 Chinese patients with oncocytoma of salivary gland origin, a rare benign tumour composed exclusively of large epithelial cells with eosinophilic granular cytoplasm (oncocytes).
  • In summary, clinical diagnosis for an oncocytoma is challenging for its similar features to other benign tumours.
  • Histopathological diagnosis is reliable with histochemical and electron microscopic conformation of the oncocytes, but differential diagnosis is still challenging.
  • [MeSH-major] Adenoma, Oxyphilic / pathology. Antibodies, Antinuclear / metabolism. Antibodies, Monoclonal / metabolism. Palatal Neoplasms / pathology. Parotid Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Child. China. Diagnosis, Differential. Female. Humans. Male. Microscopy, Electron. Middle Aged. Neoplasm Proteins / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19796983.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Antinuclear; 0 / Antibodies, Monoclonal; 0 / MIB-1 antibody; 0 / Neoplasm Proteins
  •  go-up   go-down


59. Gondivkar SM, Indurkar A, Degwekar S, Bhowate R: Primary oral malignant melanoma--a case report and review of the literature. Quintessence Int; 2009 Jan;40(1):41-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary oral malignant melanoma--a case report and review of the literature.
  • Malignant melanoma is a neoplasm of melanocytic origin that arises from a benign melanocytic lesion or de novo from melanocytes within otherwise normal mucosa or skin.
  • Melanoma arising from the mucosal surfaces of the head and neck is a very rare disease and is considered among the most deadly of all human neoplasms.
  • Although it comprises 1.3% of all cancers, malignant melanoma of the oral cavity accounts for only 0.2% to 8.0% of all reported melanomas.
  • Because most mucosal melanotic lesions are painless in their early stages, the diagnosis is unfortunately often delayed until symptoms resulting from ulceration or growth are noted.
  • Oral malignant melanoma has an extremely poor prognosis.
  • For prevention of oral mucosal melanomas, any solitary pigmentation that has no obvious explanation should be always biopsied.
  • [MeSH-major] Gingival Neoplasms / pathology. Melanoma / pathology
  • [MeSH-minor] Adult. Humans. Male. Maxilla / surgery. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19159022.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 19
  •  go-up   go-down


60. Gołkowski F, Buziak-Bereza M, Huszno B, Bałdys-Waligórska A, Stefańska A, Budzyński A, Okoń K, Chrzan R, Urbanik A: The unique case of adrenocortical malignant and functioning oncocytic tumour. Exp Clin Endocrinol Diabetes; 2007 Jun;115(6):401-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The unique case of adrenocortical malignant and functioning oncocytic tumour.
  • Only a little more than thirty cases of adrenal oncocytoma, mainly nonfunctioning and benign, have been reported in the literature.
  • Abnormal laboratory findings: oral glucose tolerance test revealed diabetes, elevated serum dehydroepiandrosterone-sulfate (1101.9 microg/dl; normal, 59-452), elevated serum cortisol following overnight 1 mg dexamethasone test (5.1 microg/dl; normal, <1.8), increased urinary excretion of 17- hydroxycorticosteroids (18.1 mg/24 h; normal, 2.0-7.0) with pathological response to high-dose dexamethason test (16.6 mg/24).
  • On laparotomy, the lesion was considered unresectable because of evident - confirmed by intraoperative ultrasound - tumour infiltration of the inferior caval vein.
  • The large biopsy specimen was obtained for histological examination in which tumour fulfilled criteria proposed by Bisceglia et al. for adrenocortical oncocytic borderline tumour.
  • The presented case appears to be the first malignant and functioning adrenocortical oncocytic tumour reported and confirms the complexity of its biology.
  • [MeSH-major] Adenoma, Oxyphilic / pathology. Adrenal Cortex Neoplasms / pathology
  • [MeSH-minor] Antineoplastic Agents, Hormonal / administration & dosage. Humans. Male. Middle Aged. Mitotane / administration & dosage. Neoplasm Proteins / metabolism. Venae Cavae / pathology

  • Hazardous Substances Data Bank. MITOTANE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17701888.001).
  • [ISSN] 0947-7349
  • [Journal-full-title] Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
  • [ISO-abbreviation] Exp. Clin. Endocrinol. Diabetes
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Neoplasm Proteins; 78E4J5IB5J / Mitotane
  •  go-up   go-down


61. Chandrasekar T, Ramani P, Anuja N, Karthikeyan R, Abhilash PR, Narayan V, Giri VV: Unilocular cystic sebaceous lymphadenoma: a rare tumour. Ann R Coll Surg Engl; 2007 May;89(4):1-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unilocular cystic sebaceous lymphadenoma: a rare tumour.
  • The recognition of key histological features will readily allow differentiation of this unique neoplasm from its benign and malignant mimics.
  • [MeSH-major] Adenolymphoma / pathology. Parotid Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Med Inform Decis Mak. 2006;6:24 [16762051.001]
  • (PMID = 17535604.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1963539
  •  go-up   go-down


62. Gómez Oliveira G, García-Rozado A, Luaces Rey R: Intraosseous mandibular hemangioma. A case report and review of the literature. Med Oral Patol Oral Cir Bucal; 2008 Aug;13(8):E496-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraosseous vascular lesions are rare conditions, comprising only 0.5% to 1% of all intraosseous tumors.
  • According to the World Health Organization, hemangiomas are benign vasoformative neoplasms of endothelial origin.
  • Some authors believe that it is a true neoplasm, whereas others state it is a hamartomatous lesion.
  • Differential diagnosis includes neoplasms such as ameloblastoma, cystic lesions such as residual cyst, keratocyst and fibro-osseous lesions such as fibrous dysplasia.
  • Clinical, radiological and histological features of this unusual tumor are described.
  • [MeSH-major] Hemangioma. Mandibular Neoplasms

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18667983.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 10
  •  go-up   go-down


63. Koshy S, George M, Gupta A, Daniel RT: Extended osteoplastic maxillotomy for total excision of giant multicompartmental juvenile nasopharyngeal angiofibroma. Indian J Dent Res; 2008 Oct-Dec;19(4):366-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Juvenile nasopharyngeal angiofibroma (JNA) is a rare vascular neoplasm occurring almost exclusively in adolescent males.
  • Although benign, it is often locally aggressive and can erode into surrounding tissues and structures resulting in significant morbidity and mortality.
  • [MeSH-major] Angiofibroma / surgery. Maxilla / surgery. Nasopharyngeal Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Osteotomy / methods
  • [MeSH-minor] Adolescent. Cranial Fossa, Middle / surgery. Craniotomy / methods. Humans. Male. Neoplasm Invasiveness. Nose Neoplasms / surgery. Palate / surgery. Paranasal Sinus Neoplasms / surgery. Sphenoid Sinus / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19075445.001).
  • [ISSN] 0970-9290
  • [Journal-full-title] Indian journal of dental research : official publication of Indian Society for Dental Research
  • [ISO-abbreviation] Indian J Dent Res
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


64. Martínez De Pablo MI, Iranzo P, Mascaró JM, Llambrich A, Baradad M, Herrero C: Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol; 2005;85(3):233-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
  • Paraneoplastic pemphigus is a life-threatening autoimmune bullous disease associated with neoplasia, generally of lymphoid origin.
  • These cases were generally associated with benign neoplasms.
  • We report here the case of a patient with paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma who had a surprisingly good response to systemic corticosteroids and remains free of lesions more than 3 years later despite progression of her neoplasm.
  • [MeSH-major] Lymphoma, B-Cell / diagnosis. Paraneoplastic Syndromes / diagnosis. Pemphigus / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Drug Administration Schedule. Female. Glucocorticoids / administration & dosage. Humans. Oral Ulcer / pathology. Prednisone / administration & dosage

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Pemphigus.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • MedlinePlus Health Information. consumer health - Pemphigus.
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16040408.001).
  • [ISSN] 0001-5555
  • [Journal-full-title] Acta dermato-venereologica
  • [ISO-abbreviation] Acta Derm. Venereol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Glucocorticoids; VB0R961HZT / Prednisone
  •  go-up   go-down


65. Jezewska E, Tulibacki M, Tomaszewska M, Nowaczewska K, Oledzka I, Kukwa A: [Removing illness changes related with ORL in laser-clinic in 2005]. Otolaryngol Pol; 2007;61(1):25-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are 47 cases presented in article (28 women and 19 men) from who pieces of nasal cavity, oral cavity or throat were taken or illness changes have been curing.
  • Group No 1 containing 11 men and 10 women with removing changes in nasal cavity.
  • Group No 3 in which changes in oral cavity were removed where were 4 men and 8 women.
  • RESULTS: Among majority patients removed pices were proliferation of neoplasm - benign type (20 patients).
  • In 2 cases were papilloma and 4 causes were malignant neoplasm.
  • Control visits did not show the increase of illness (except malignant neoplasm).
  • CONCLUSIONS: Laser ND-YAG may be used to remove egzofitical changes and to take some pices in case of neoplasm.
  • Using laser technology high precision is possible and deep penetration of laser make the operations safer in case of neoplasm.
  • [MeSH-major] Head and Neck Neoplasms / surgery. Laser Therapy / methods. Precancerous Conditions / surgery
  • [MeSH-minor] Anesthesia, Local. Esophagus / surgery. Female. Humans. Laryngeal Neoplasms / therapy. Male. Nasopharyngeal Neoplasms / therapy. Pharyngeal Neoplasms / therapy. Poland. Retrospective Studies. Tongue Neoplasms / therapy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17605414.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


66. Micheli A, Trapani S, Brizzi I, Campanacci D, Resti M, de Martino M: Myositis ossificans circumscripta: a paediatric case and review of the literature. Eur J Pediatr; 2009 May;168(5):523-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myositis ossificans circumscripta (MOC), characterised by non-neoplastic heterotopic bone formation in soft tissue and skeletal muscle, is rare in children.
  • At onset, it is difficult to distinguish MOC from a musculoskeletal infection or neoplasm, particularly in absence of trauma, and a biopsy is frequently required.
  • The magnetic resonance imaging revealed an enlarged mass with marked enhancement of the lesion and a central, irregular non-enhanced area due to necrosis.
  • Three months after diagnosis, surgical excision was performed.
  • Our case study confirms the good prognosis of MOC and underlines how this benign condition should be considered in children presenting a tender and painful soft-tissue swelling.
  • [MeSH-major] Bone and Bones. Musculoskeletal Diseases. Myositis Ossificans / diagnosis. Myositis Ossificans / physiopathology
  • [MeSH-minor] Anti-Bacterial Agents / therapeutic use. Anti-Inflammatory Agents / therapeutic use. Biopsy. Child. Diagnosis, Differential. Humans. Lymphadenitis / diagnosis. Magnetic Resonance Imaging. Male. Muscle, Skeletal / metabolism. Muscle, Skeletal / pathology. Necrosis / pathology. Osteoblasts / metabolism. Sarcoma / pathology. Soft Tissue Injuries / diagnosis. Soft Tissue Injuries / metabolism. Soft Tissue Injuries / pathology

  • Genetic Alliance. consumer health - Myositis.
  • Genetic Alliance. consumer health - Myositis ossificans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Orthop Trauma Surg. 2001;121(4):234-7 [11317689.001]
  • [Cites] Orthop Rev. 1992 Nov;21(11):1319-26 [1461667.001]
  • [Cites] Can J Surg. 2007 Dec;50(6):E21-2 [18067695.001]
  • [Cites] Arthroscopy. 1998 Jul-Aug;14(5):522-6 [9681548.001]
  • [Cites] Surg Today. 2006;36(7):619-22 [16794797.001]
  • [Cites] J Bone Joint Surg Br. 1994 Jul;76(4):607-9 [8027150.001]
  • [Cites] Clin Imaging. 1991 Apr-Jun;15(2):130-4 [1913313.001]
  • [Cites] J Pediatr Surg. 2002 Nov;37(11):1621-2 [12407551.001]
  • [Cites] Int J Surg Pathol. 2006 Jan;14(1):37-41 [16501833.001]
  • [Cites] Joint Bone Spine. 2004 Mar;71(2):144-6 [15050200.001]
  • [Cites] An Pediatr (Barc). 2004 Apr;60(4):373-5 [15033117.001]
  • [Cites] Radiographics. 1990 Sep;10 (5):945-9 [2217980.001]
  • [Cites] AJR Am J Roentgenol. 1976 Jan;126(1):32-40 [175681.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2006 Apr;263(4):331-5 [16133463.001]
  • [Cites] APMIS. 1991 May;99(5):482-6 [2043360.001]
  • [Cites] Clin Orthop Relat Res. 1976 Jul-Aug;(118):151-2 [954268.001]
  • [Cites] Skeletal Radiol. 1991;20(7):539-42 [1754917.001]
  • [Cites] Skeletal Radiol. 1995 Feb;24(2):139-41 [7747181.001]
  • [Cites] Pediatr Surg Int. 1999;15(3-4):287-9 [10370048.001]
  • [Cites] Can Med Assoc J. 1977 Jan 8;116(1):65-6 [832222.001]
  • [Cites] Acta Orthop Belg. 1996 Sep;62(3):177-9 [8890543.001]
  • [Cites] Pediatr Radiol. 2000 Jul;30(7):451-9 [10929363.001]
  • [Cites] Clin Orthop Relat Res. 1971 Sep;79:42-3 [5097465.001]
  • [Cites] J Radiol. 2003 Jan;84(1):54-6 [12637889.001]
  • [Cites] Pediatr Pathol. 1992 Mar-Apr;12(2):223-9 [1570239.001]
  • [Cites] Eur Radiol. 1999;9(4):662-4 [10354880.001]
  • [Cites] Skeletal Radiol. 1992;21(8):503-7 [1465642.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2001 Feb;30(2):152-4 [11234943.001]
  • [Cites] J Orthop Surg (Hong Kong). 2006 Aug;14(2):219-21 [16914794.001]
  • [Cites] AJR Am J Roentgenol. 1991 Dec;157(6):1243-8 [1950874.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2007 Aug 01;12(4):E277-80 [17664912.001]
  • [Cites] Orthopedics. 1989 Apr;12 (4):599-602 [2710719.001]
  • [Cites] Skeletal Radiol. 1992;21(2):87-101 [1566115.001]
  • [Cites] J Bone Joint Surg Am. 1958 Apr;40-A(2):279-98 [13539055.001]
  • (PMID = 19130083.001).
  • [ISSN] 1432-1076
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anti-Inflammatory Agents
  • [Number-of-references] 35
  •  go-up   go-down


67. Chung J, Namkoong S, Jung KE, Park JW, Park BC, Cinn YW, Kim MH: A Case of Gardner's Syndrome Associated with Desmoid Tumor. Ann Dermatol; 2010 Nov;22(4):418-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A Case of Gardner's Syndrome Associated with Desmoid Tumor.
  • Desmoid tumors are uncommon benign neoplasm of the fibroblasts.
  • Herein, we report a 16-year-old woman with Gardner's syndrome complicated by desmoid tumors on the right subscapular area.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21165211.001).
  • [ISSN] 2005-3894
  • [Journal-full-title] Annals of dermatology
  • [ISO-abbreviation] Ann Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2991718
  • [Keywords] NOTNLM ; Desmoid tumor / Familial polyposis coli / Gardner's syndrome
  •  go-up   go-down


68. Bala A, Robbins P, Knuckey N, Wong G, Lee G: Spinal chondromyxoid fibroma of C2. J Clin Neurosci; 2006 Jan;13(1):140-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondromyxoid fibroma of bone (CMF) is a rare benign primary bone neoplasm accounting for less than 0.5% of all primary bone neoplasms.
  • The spine is an uncommon site for this tumour, with forty-two cases reported in the modern English literature.
  • The patient underwent stereotactic CT guided trans-oral curettage of the lesion with iliac bone graft and anterior fusion of C2 and C3.
  • This is the second reported case of this rare tumour in this location.
  • [MeSH-major] Bone Neoplasms / pathology. Chondroblastoma / pathology. Fibroma / pathology. Spinal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16410218.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 39
  •  go-up   go-down


69. Brasileiro BF, Martins-Filho PR, Piva MR, da Silva LC, Nonaka CF, Miguel MC: Myofibroma of the oral cavity. A rare spindle cell neoplasm. Med Oral Patol Oral Cir Bucal; 2010 Jul;15(4):e596-600
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myofibroma of the oral cavity. A rare spindle cell neoplasm.
  • Myofibroma is an uncommon spindle cell neoplasm rarely found in oral cavity.
  • In the oral cavity, myofibroma occurs within the submucosal or intramuscular tissue and has a predilection by the tongue, buccal mucosa and lips.
  • Misdiagnosis included benign and malignant spindle cell lesions of nerve tissue or smooth muscle origin, such as neurofibroma, leiomyoma and sarcomas.
  • Thus, immunohistochemical staining is a useful tool to identify the nature of neoplastic cells and to reach an accurate diagnosis.
  • [MeSH-major] Myofibroma / pathology. Tongue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20038894.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


70. Martín-Ezquerra G, Salgado R, Toll A, Gilaberte M, Baró T, Alameda Quitllet F, Yébenes M, Solé F, Garcia-Muret M, Espinet B, Pujol RM: Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours. Br J Dermatol; 2010 Nov;163(5):1028-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours.
  • BACKGROUND: Oncogenesis in the oral cavity is believed to result from genetic alterations that cause a stepwise transformation of the mucosa to invasive carcinoma.
  • In oral squamous cell carcinoma (OSCC) multiple cytogenetic abnormalities have been reported, but their practical significance remains uncertain.
  • METHODS: Fifty-one consecutive samples of OSCC, nine lymph node biopsies showing metastatic spread from OSCC, 16 biopsies diagnosed as oral leucoplakia (OLK), 13 samples corresponding to oral lichen planus (OLP) and 14 samples from normal oral mucosa were included in the study.
  • The genetic and protein status of the CCND1, MYC, EGFR, ERBB2 oncogenes and the TP53 tumour suppressor gene were assessed by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC).
  • Overexpression of p53, Myc, Cyclin D1, c-erbB-2 and epidermal growth factor receptor (EGFR) was more prevalent in malignant samples than benign samples (P < 0·05).
  • Evaluation of the genetic status of TP53, MYC, CCND1, ERBB2 and EGFR may be an additional diagnostic tool in distinguishing benign from malignant oral lesions in histopathologically challenging cases.
  • [MeSH-major] Carcinoma, Squamous Cell / genetics. Gene Dosage. Mouth Neoplasms / genetics. Oncogenes / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. Biopsy. Cyclin D1 / genetics. Cyclin D1 / metabolism. Female. Genes, p53 / genetics. Humans. Lymph Nodes. Male. Middle Aged. Neoplasm Metastasis / genetics. Proto-Oncogene Proteins c-myc / genetics. Proto-Oncogene Proteins c-myc / metabolism. Receptor, Epidermal Growth Factor / genetics. Receptor, Epidermal Growth Factor / metabolism. Receptor, ErbB-2 / genetics. Receptor, ErbB-2 / metabolism


71. Chi AC, Barnes JD, Budnick S, Agresta SV, Neville B: Rhabdomyosarcoma of the maxillary gingiva. J Periodontol; 2007 Sep;78(9):1839-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Rhabdomyosarcoma is a malignant neoplasm of primitive mesenchyme exhibiting skeletal muscle differentiation.
  • Oral rhabdomyosarcoma is rare and accounts for only 0.04% of all head and neck malignancies.
  • Many of the tumor cells exhibited abundant eosinophilic cytoplasm.
  • Immunohistochemical stains showed the tumor cells to be positive for desmin, myogenin, and myogenic differentiation 1 (MyoD1).
  • A diagnosis of embryonal rhabdomyosarcoma was made.
  • CONCLUSIONS: Oral rhabdomyosarcoma can develop insidiously.
  • Pain is a variable presenting symptom, and early lesions may be mistaken for benign neoplastic, inflammatory, or infectious processes.
  • [MeSH-major] Gingival Neoplasms / pathology. Rhabdomyosarcoma / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17760557.001).
  • [ISSN] 0022-3492
  • [Journal-full-title] Journal of periodontology
  • [ISO-abbreviation] J. Periodontol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 51
  •  go-up   go-down


72. Cudney N, Ochs MW, Johnson J, Roccia W, Collins BM, Costello BJ: A unique presentation of a squamous cell carcinoma in a pregnant patient. Quintessence Int; 2010 Jul-Aug;41(7):581-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This report discusses the diagnosis and treatment of this unusual scenario involving progression of a benign lesion to a malignant hybrid.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Carcinoma, Verrucous / diagnosis. Mandibular Neoplasms / diagnosis. Pregnancy Complications, Neoplastic / diagnosis
  • [MeSH-minor] Adult. Bone Transplantation. Female. Follow-Up Studies. Humans. Mandibular Diseases / diagnosis. Neoadjuvant Therapy. Neoplasm Staging. Odontogenic Cysts / diagnosis. Pregnancy. Reconstructive Surgical Procedures. Skin Transplantation

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20614045.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


73. Hoseini AT, Razavi SM, Khabazian A: Lipoma in oral mucosa: two case reports. Dent Res J (Isfahan); 2010;7(1):41-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoma in oral mucosa: two case reports.
  • Lipoma is a common tumor of soft tissue.
  • Its location on the oral mucosa is rare, representing 1% to 5% of benign oral tumors although it is the most mesenchymal tumor of the trunk and proximal por-tions of extremities.
  • Lipoma of the oral cavity may occur in any region.
  • The buccal mucosa, tongue, and floor of the mouth are among the common locations.
  • The overlying epithelium is intact, and superficial blood vessels are usually evident over the tumor.
  • Other benign connective tissue lesions such as granular cell tumor, neurofibroma, traumatic fibroma and salivary gland lesions (mucocele and mixed tumor) might be included in differential diagnosis.
  • We present two cases of oral lipoma in unusual locations: one in junction of soft and hard palate and the other in tongue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Periodontol. 2001 Feb;28(2):109-12 [11168734.001]
  • [Cites] Int J Oral Surg. 1982 Feb;11(1):30-5 [6811454.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Feb;93(2):171-3 [11862206.001]
  • [Cites] J Oral Pathol Med. 2006 Jul;35(6):376-8 [16762019.001]
  • [Cites] J Med Case Rep. 2008;2:382 [19077289.001]
  • [Cites] J Oral Rehabil. 1995 Jan;22(1):83-5 [7897564.001]
  • [Cites] Int J Oral Surg. 1978 Jun;7(3):162-6 [99380.001]
  • [Cites] J Laryngol Otol. 2002 May;116(5):395-7 [12081004.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Feb;32(1):49-53 [12653233.001]
  • [Cites] Med Oral. 2004 Mar-Apr;9(2):166-7, 163-6 [14990884.001]
  • [Cites] Ann Acad Med Singapore. 2004 Jul;33(4 Suppl):72-6 [15389313.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2006 Aug;11(5):E437-9 [16878062.001]
  • [Cites] J Can Dent Assoc. 2007 Jun;73(5):431-4 [17555654.001]
  • [Cites] Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):754-8 [18293712.001]
  • [Cites] Rev Fac Odontol P Alegre. 1967;9:163-8 [5256791.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Jan;57(1):77-80 [6582440.001]
  • [Cites] Niger J Med. 2001 Oct-Dec;10(4):189-91 [11806003.001]
  • (PMID = 21448446.001).
  • [ISSN] 2008-0255
  • [Journal-full-title] Dental research journal
  • [ISO-abbreviation] Dent Res J (Isfahan)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Other-IDs] NLM/ PMC3065337
  • [Keywords] NOTNLM ; Differential diagnosis / Lipoma / Pathology
  •  go-up   go-down


74. De Corso E, Politi M, Marchese MR, Pirronti T, Ricci R, Paludetti G: Advanced giant cell reparative granuloma of the mandible: radiological features and surgical treatment. Acta Otorhinolaryngol Ital; 2006 Jun;26(3):168-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Giant cell reparative granuloma accounts for 1%-7% of all benign lesions of the jaw.
  • [MeSH-major] Granuloma, Giant Cell / radiography. Granuloma, Giant Cell / surgery. Mandibular Neoplasms / radiography. Mandibular Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Ilium / transplantation. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Zhonghua Yi Xue Za Zhi (Taipei). 1999 Oct;62(10):738-42 [10533306.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1959 Nov;12:1285-95 [13795191.001]
  • [Cites] Radiographics. 2001 Sep-Oct;21(5):1283-309 [11553835.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jul;60(7):756-61 [12089688.001]
  • [Cites] Am J Clin Pathol. 1966 Apr;45(4):437-47 [5910047.001]
  • [Cites] J Oral Surg. 1971 Feb;29(2):110-5 [5279095.001]
  • [Cites] Arch Otolaryngol. 1984 Feb;110(2):116-9 [6696681.001]
  • [Cites] J Oral Maxillofac Surg. 1986 Sep;44(9):708-13 [3462363.001]
  • [Cites] Int J Oral Maxillofac Surg. 1986 Dec;15(6):780-5 [3100684.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jul;64(1):44-9 [3475657.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Feb;65(2):255-61 [3422730.001]
  • [Cites] J Oral Maxillofac Surg. 1988 May;46(5):376-84 [3163371.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Jul;66(1):121-2 [3165509.001]
  • [Cites] J Am Dent Assoc. 1988 Nov;117(6):731-3 [3198881.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jun;81(6):720-6 [8784905.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Oct;17(9):1791-3 [8896640.001]
  • [Cites] J Hand Surg Am. 1997 Jul;22(4):732-6 [9260635.001]
  • [Cites] J Craniofac Surg. 1998 Jan;9(1):45-7 [9558566.001]
  • [Cites] Skeletal Radiol. 1998 Oct;27(10):584-7 [9840398.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1953 Jan;6(1):159-75 [13026160.001]
  • [Cites] Radiology. 2001 May;219(2):334-45 [11323454.001]
  • (PMID = 17063987.001).
  • [ISSN] 0392-100X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2639959
  •  go-up   go-down


75. Gomes CC, Gomez RS: Odontogenic keratocyst: a benign cystic neoplasm? Oral Oncol; 2007 Jul;43(6):619-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Odontogenic keratocyst: a benign cystic neoplasm?

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17174142.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, Cell Surface; 0 / patched receptors
  •  go-up   go-down


76. Collins S, McKiernan J, Landman J: Update on the epidemiology and biology of renal cortical neoplasms. J Endourol; 2006 Dec;20(12):975-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Update on the epidemiology and biology of renal cortical neoplasms.
  • A new era is developing in the understanding of the diagnosis, classification, and management of renal-cell carcinoma (RCC).
  • Nevertheless, many incidental lesions prove to be benign, so there is renewed enthusiasm for biopsy before treatment is selected.
  • Genetic conditions associated with RCC, such as Von Hippel Lindau and Birt-Hogg-Dube syndromes, along with genetic analyses of tumors, have provided considerable insight into the pathogenesis of these lesions.
  • Bevacizumab, a monoclonal antibody that acts as a competitive blocker of the VEGF receptor; sorafenib, an oral well-tolerated tyrosine kinase inhibitor that blocks the intracellular second-messenger system associated with the VEGF receptor; sunitinib, a multitarget inhibitor of kinases associated with the VEGF and PDGF receptors; temsirolimus (CCI-779), a kinase blocker that inhibits the mammalian target of rapamycin pathway; and erlotinib, an inhibitor of the tyrosine kinases associated with the EGF receptor, have shown promise.

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17206887.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 72
  •  go-up   go-down


77. Driemel O, Maier H, Kraft K, Haase S, Hemmer J: Flow cytometric DNA ploidy in salivary gland tumours. Oncol Rep; 2005 Jan;13(1):161-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study on 279 tumours of the salivary glands was conducted to analyse whether the assessment of DNA ploidy by flow cytometry may assist histopathology in discriminating benign from malignant types of tumours.
  • The group of benign tumours included 164 pleomorphic adenomas, 51 Warthin's tumours, 7 basal cell adenomas, 2 lipomas as well as 5 other different tumours.
  • All of the 229 benign tumours were diploid.
  • The malignant tumours consisted of 18 adenoid cystic adenomas, 10 mucoepidermoid carcinomas, 5 acinic cell carcinomas, 5 carcinoma in pleomorphic adenoma as well as of 12 other malignancies belonging to 7 different tumour entities.
  • Examination of consecutive slides actually revealed small assemblies of carcinoma cells that required a final diagnosis as non-invasive carcinoma in pleomorphic adenoma.
  • [MeSH-major] DNA, Neoplasm / analysis. Flow Cytometry. Ploidies. Salivary Gland Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15583819.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


78. Tosios KI, Koutlas IG, Kyriakopoulos VF, Balta M, Theologie-Lygidakis N, Vardas E, Iatrou I: Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct;110(4):492-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes.
  • Angiomyolipoma (AML) is the most common benign mesenchymal neoplasm of the kidneys with well-established clinical and morphological features.
  • The oral and maxillofacial pathology literature contains several examples that identify angiomyomatous proliferations of the oral mucosa that contain an adipocytic component as analogous to classic renal AMLs although they differ significantly in their immunohistochemical phenotype.
  • Herein, through review of the pertinent oral pathology literature and the detailed description of 2 lesions, one an oral angiomyoma with an adipocytic component and the other an apparently hamartomatous angioleiomyomatous proliferation with adipocytes, we provide, in our opinion, a solid argument against the use of the term AML for non-PEComatous oral tumors.
  • [MeSH-major] Angiomyolipoma / classification. Mouth Neoplasms / classification. Terminology as Topic

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20674420.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Desmin; 0 / S100 Proteins; 0 / von Willebrand Factor
  •  go-up   go-down


79. Iwata T, Nishiyama N, Nagano K, Izumi N, Tsukioka T, Hanada S, Kimura T, Kudoh S, Hirata K, Suehiro S: Squamous cell carcinoma presenting as a solitary growing cyst in lung: a diagnostic pitfall in daily clinical practice. Ann Thorac Cardiovasc Surg; 2009 Jun;15(3):174-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thin-walled cavitary lung cancer is a rare entity; however, it could be a pitfall in the diagnosis of such radiographically benign-looking lesions, especially without an obvious solid, nodular, or tumorous appearance in the lesion.
  • We herein report a rare case of lung cancer successfully treated by surgical resection that appeared as a gradually growing cystic lesion mimicking benign emphysematous disease, with a review of the literature.
  • He received clarithromycin by daily oral administration, and the bloody sputa soon disappeared.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Cysts / diagnosis. Diagnostic Errors / prevention & control. Lung Neoplasms / diagnosis. Solitary Pulmonary Nodule / diagnosis
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols. Biopsy. Carboplatin / administration & dosage. Chemotherapy, Adjuvant. Frozen Sections. Humans. Lymph Node Excision. Lymphatic Metastasis. Male. Neoplasm Staging. Paclitaxel / administration & dosage. Pneumonectomy. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19597393.001).
  • [ISSN] 2186-1005
  • [Journal-full-title] Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
  • [ISO-abbreviation] Ann Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  • [Number-of-references] 5
  •  go-up   go-down


80. Nasseri K, Mills JR: Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005. Cancer Detect Prev; 2009;32(5-6):363-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005.
  • The purpose of this study was to compare the epidemiology of primary brain tumors in this ethnic population with the non-Hispanic, non-Middle Eastern White (NHNMW) in California.
  • Data for 683 cases of primary brain tumors (429 benign, 238 malignant, 16 uncertain) in the ME and 15,589 cases (8352 benign, 6812 malignant, 425 uncertain) in the NHNMW were available for this study.
  • RESULTS: ME patients were significantly (p < 0.05) younger and their age-adjusted incidence rates per 100,000 for benign tumors of 10.0 in men and 17.6 in women were higher than similar rates of 7.3 and 10.6 in the NHNMW group (p < 0.05).
  • Rates for malignant tumors were similar.
  • Also increased were benign tumors of the pituitary and pineal glands.
  • The overall mortality in patients with benign tumors was significantly lower than malignant tumors.
  • CONCLUSIONS: This study presents a significantly high incidence of benign meningioma in the ME population in California.
  • This may be due to higher susceptibility or exposure of this ethnic group to the risk factor(s) for this neoplasm.
  • Considering the reported causal association of benign meningioma with childhood radiation exposure from Israel, exposure to this risk factor in this ethnic group needs to be evaluated in future studies.
  • [MeSH-major] Brain Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. California / epidemiology. Child. Child, Preschool. Continental Population Groups / statistics & numerical data. European Continental Ancestry Group / statistics & numerical data. Female. Humans. Incidence. Infant. Infant, Newborn. Male. Meningeal Neoplasms / epidemiology. Meningeal Neoplasms / ethnology. Meningioma / epidemiology. Meningioma / ethnology. Middle Aged. Middle East / ethnology. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):470-80 [18206397.001]
  • [Cites] Cancer Causes Control. 2008 Dec;19(10):1183-91 [18543070.001]
  • [Cites] Cancer Detect Prev. 2007;31(5):424-9 [18023539.001]
  • [Cites] Neuro Oncol. 1999 Jul;1(3):205-11 [11554389.001]
  • [Cites] Health Inf Manag. 1997 Mar-May;27(1):31-8 [10169442.001]
  • [Cites] Cancer. 2005 Dec 15;104(12):2798-806 [16288487.001]
  • [Cites] Neuro Oncol. 2002 Oct;4(4):278-99 [12356358.001]
  • [Cites] Am J Epidemiol. 2000 Feb 1;151(3):266-72 [10670551.001]
  • [Cites] Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):405-11 [18159978.001]
  • [Cites] Neuroepidemiology. 1989;8(6):283-95 [2586698.001]
  • [Cites] Cancer Detect Prev. 2003;27(3):203-8 [12787727.001]
  • [Cites] Neoplasma. 2001;48(6):442-4 [11949834.001]
  • [Cites] Radiat Res. 2005 Apr;163(4):424-32 [15799699.001]
  • [Cites] Dermatol Surg. 2001 Jul;27(7):667-9 [11442620.001]
  • [Cites] Br J Surg. 1977 Jul;64(7):457-9 [922301.001]
  • [Cites] J Carcinog. 2005 Nov 10;4:21 [16283945.001]
  • [Cites] Calif Med. 1949 Mar;70(3):189-93 [18112454.001]
  • (PMID = 19588542.001).
  • [ISSN] 1525-1500
  • [Journal-full-title] Cancer detection and prevention
  • [ISO-abbreviation] Cancer Detect. Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA103457; United States / NCI NIH HHS / PC / N01-PC-35139; United States / NCI NIH HHS / CA / R03 CA103457-02; United States / NCCDPHP CDC HHS / DP / U58 DP000807; United States / NCI NIH HHS / CA / N01PC54404; United States / NCI NIH HHS / CA / R03 CA103457; United States / NCI NIH HHS / CA / N01PC35136; United States / NCI NIH HHS / CA / N01PC35139; United States / NCI NIH HHS / PC / N01-PC-54404; United States / NCI NIH HHS / PC / N01-PC-35136; United States / NCCDPHP CDC HHS / DP / 1U58DP00807-01
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS140088; NLM/ PMC2785228
  •  go-up   go-down


81. Anil S: Solitary plasmacytoma of the maxilla--a case report and review of the literature. Gen Dent; 2007 Jan-Feb;55(1):39-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Plasma cell neoplasms have been classified as multiple myeloma, solitary plasmacytoma, and extramedullary plasmacytoma.
  • Some lesions appear to be benign and do not recur after complete removal, while others are locally invasive.
  • The dense plasma cell infiltration that commonly is associated with inflammatory lesions within the oral tissues makes diagnosing plasmacytoma at this site problematic.
  • A CT scan showed that the tumor mass occupied the right maxillary sinus and the lateral wall of the nasal cavity.
  • The tumor cells were composed of densely packed, round, polygonal cell structures that were scattered in relatively sparse stoma.
  • [MeSH-major] Maxillary Neoplasms / pathology. Maxillary Sinus Neoplasms / pathology. Palatal Neoplasms / pathology. Plasmacytoma / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17333965.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


82. Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF: Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging; 2009 Jun;36(6):919-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • False-positive PET/CT findings were mainly related to benign FDG uptake in the intestine due to benign or precancerous polyps or physiological FDG uptake in other head and neck regions.
  • [MeSH-major] Fluorodeoxyglucose F18. Head and Neck Neoplasms / diagnostic imaging. Neoplasms, Multiple Primary / diagnostic imaging. Neoplasms, Squamous Cell / diagnostic imaging
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. False Positive Reactions. Female. Humans. Male. Middle Aged. Neoplasm Staging. Neoplasms, Second Primary / diagnostic imaging. Neoplasms, Second Primary / pathology. Neoplasms, Second Primary / therapy. Positron-Emission Tomography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1173-8 [14623746.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):703-7 [12049568.001]
  • [Cites] Head Neck. 2002 Apr;24(4):345-9 [11933176.001]
  • [Cites] Neuroradiology. 2008 Nov;50(11):969-79 [18600319.001]
  • [Cites] Radiother Oncol. 2008 May;87(2):221-9 [18410977.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Feb;124(2):208-12 [11226943.001]
  • [Cites] Otolaryngol Head Neck Surg. 2007 Jul;137(1):130-7 [17599580.001]
  • [Cites] Head Neck. 2007 Nov;29(11):986-95 [17563906.001]
  • [Cites] Head Neck. 1989 Sep-Oct;11(5):426-30 [2807882.001]
  • [Cites] J Nucl Med. 2004 Nov;45(11):1804-10 [15534047.001]
  • [Cites] J Comput Assist Tomogr. 1999 Jul-Aug;23 (4):603-8 [10433294.001]
  • [Cites] Cancer. 1995 Mar 15;75(6):1343-53 [7882285.001]
  • [Cites] Am J Surg. 1987 Oct;154(4):434-8 [3661848.001]
  • [Cites] Nucl Med Commun. 2005 Aug;26(8):671-87 [16000985.001]
  • [Cites] Oral Oncol. 2006 Mar;42(3):275-80 [16266820.001]
  • [Cites] Laryngoscope. 2007 Jul;117(7):1173-9 [17603315.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):467-76 [2674075.001]
  • [Cites] Laryngoscope. 2003 May;113(5):888-91 [12792328.001]
  • [Cites] Ann Nucl Med. 2006 Nov;20(9):597-604 [17294670.001]
  • [Cites] Oral Oncol. 2003 Sep;39(6):547-51 [12798396.001]
  • [Cites] Cancer. 1953 Sep;6(5):963-8 [13094644.001]
  • [Cites] Am J Surg. 1964 Oct;108:552-7 [14211447.001]
  • [Cites] AJR Am J Roentgenol. 2004 May;182(5):1129-32 [15100107.001]
  • (PMID = 19205699.001).
  • [ISSN] 1619-7089
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


83. Marques YM, de Lima Mde D, de Melo Alves Sde M Jr, Soares FA, de Araújo VC, Pinto Ddos S Jr, Mantesso A: Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncol; 2008 Sep;44(9):903-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
  • The pAkt protein is closely related to Mdm2, and has not been previously reported in salivary gland tumors.
  • Overexpression of Mdm2 and pAkt was present in all the cell lines and tumors studied, whereas the expression of p53 and p21 proteins was considered absent.
  • In conclusion, the signaling pathway in benign salivary gland neoplasm showed an important participation of Mdm2 overexpression protein in tumor formation, progression through inactivation of p53 action, or both, and of pAkt overexpression through increased translocation of Mdm2 protein to cellular nuclei.
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Proto-Oncogene Proteins c-akt / metabolism. Proto-Oncogene Proteins c-mdm2 / metabolism. Salivary Gland Neoplasms / metabolism. Tumor Suppressor Protein p53 / metabolism
  • [MeSH-minor] Cell Line, Tumor. Genes, p53 / genetics. Humans. Immunohistochemistry. Mutation. Signal Transduction / genetics

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18485798.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Tumor Suppressor Protein p53; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down


84. Parkins GE, Armah G, Ampofo P: Tumours and tumour-like lesions of the lower face at Korle Bu Teaching Hospital, Ghana--an eight year study. World J Surg Oncol; 2007;5:48
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumours and tumour-like lesions of the lower face at Korle Bu Teaching Hospital, Ghana--an eight year study.
  • PATIENTS AND METHODS: Records of consecutive patients of all age and sex seen by the first author's team at the Department of Oral and Maxillofacial Surgery, Korle-Bu Teaching Hospital with tumours affecting the lower part of the face from January 1996 to December 2003 were retrieved, coded and entered into a database.
  • RESULTS: A total of 394 patients with oro-facial swellings were retrieved from the registry out of which 210 had lower face tumour and tumour-like lesions.
  • The most common clinical presenting features were mandibular facial swelling (63%), intra-oral swelling (55%), pain (41%) and ulceration (29%).
  • The remainder making up 20% were found in the floor of the mouth, tongue and lips.
  • Sixty-two (36.3%) had benign odontogenic tumours and thirty-one (18.1%) had non-odontogenic tumour-like lesions.
  • Fifty-four (62%) of malignant tumours were squamous cell carcinoma; 58 (93.6%) of the benign odontogenic tumours were classified as ameloblastoma.
  • The mean age at presentation of all lesions was 40.4 years with over 50% of benign lesions in patients aged between 11 and 30 years.
  • CONCLUSION: Tumours and tumour-like lesions of the lower face comprising the mandible, tongue and adjacent structures are a diverse group of neoplasm and are seen commonly in practice of Maxillofacial surgery.
  • Both malignant and benign tumours are seen in the Ghanaian population.
  • In the present study, SCC and ameloblastoma were the commonest malignant and benign odontogenic tumours seen respectively; the two representing more than 65% of all tumours.
  • [MeSH-major] Facial Neoplasms / epidemiology. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology. Mouth Neoplasms / epidemiology. Odontogenic Tumors / epidemiology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Orthod. 2001 Jun;28(2):115-8 [11395525.001]
  • [Cites] Int J Oral Maxillofac Surg. 2001 Jun;30(3):205-8 [11420902.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Jun;63(6):747-51 [15944968.001]
  • [Cites] Przegl Lek. 2004;61(10):1040-2 [15794245.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jul;88(1):11-5 [10442938.001]
  • [Cites] Oral Oncol. 2006 Feb;42(2):184-9 [16256417.001]
  • [Cites] Oral Oncol. 2006 Feb;42(2):177-83 [16256412.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Jun;63(6):811-9 [15944979.001]
  • [Cites] J N J Dent Assoc. 2002 Summer;73(3):12-5, 36 [12402528.001]
  • [Cites] Clin Imaging. 2003 Jan-Feb;27(1):59-70 [12504325.001]
  • [Cites] Acta Otorhinolaryngol Ital. 2002 Oct;22(5):295-300 [12510342.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Feb;32(1):78-83 [12653238.001]
  • [Cites] Neuroimaging Clin N Am. 2003 Aug;13(3):509-24 [14631688.001]
  • [Cites] J Can Dent Assoc. 2003 Oct;69(9):577-82 [14653933.001]
  • [Cites] Auris Nasus Larynx. 2003 Dec;30(4):447-51 [14656576.001]
  • [Cites] Rev Stomatol Chir Maxillofac. 2004 Jun;105(3):182-4 [15211218.001]
  • [Cites] J Oral Surg. 1970 Jul;28(7):490-4 [5269211.001]
  • [Cites] Rhinology. 1991 Mar;29(1):57-68 [2038656.001]
  • [Cites] Bull Tokyo Dent Coll. 1991 May;32(2):51-6 [1819443.001]
  • [Cites] J Oral Maxillofac Surg. 1996 Jan;54(1):34-8; discussion 39 [8530997.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jul;82(1):38-41 [8843452.001]
  • [Cites] Cent Afr J Med. 1996 Jun;42(6):158-61 [8870310.001]
  • [Cites] Br J Oral Maxillofac Surg. 1997 Apr;35(2):92-5 [9146865.001]
  • [Cites] Aust Dent J. 1998 Jun;43(3):172-4 [9707781.001]
  • [Cites] Int J Oral Maxillofac Surg. 1999 Aug;28(4):291-4 [10416898.001]
  • (PMID = 17484780.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1885260
  • [General-notes] NLM/ Original DateCompleted: 20070813
  •  go-up   go-down


85. Massani M, Caratozzolo E, Baldessin M, Bonariol L, Bassi N: Hepatic cystic lesion in adult: a challenging diagnosis of undifferentiated primary embryonal sarcoma. G Chir; 2010 May;31(5):225-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic cystic lesion in adult: a challenging diagnosis of undifferentiated primary embryonal sarcoma.
  • Most of these represent benign simple cysts that generally require no intervention.
  • The diagnosis of simple hepatic cysts is straightforward in the face of typical radiographic findings; however, diagnostic uncertainty, based solely on radiographic criteria alone, is not an uncommon clinical dilemma.
  • The patient had no previous history of oral contraceptive assumption or liver disease.
  • The patient was submitted to operation and resection; the final histologic diagnosis revealed a primary undifferentiated embryonal sarcoma of the liver.
  • [MeSH-major] Liver Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Neoplasms, Germ Cell and Embryonal / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Chemoembolization, Therapeutic. Cysts / diagnosis. Diagnosis, Differential. Female. Hepatectomy. Humans. Liver Diseases / diagnosis. Middle Aged. Treatment Outcome


86. Lee LT, Kwan PC, Wong YK: Novel application of artificial dermis plus autologous vital epithelial cells: improved wound epithelialization. J Chin Med Assoc; 2010 Feb;73(2):108-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of this study was to evaluate artificial dermis with the simultaneous addition of autologous epithelial cells for oral lesion defect reconstruction.
  • Surgical wounds reconstructed with artificial dermis plus scraped epithelial cells were evaluated in 5 patients with oral benign lesions or squamous cell carcinoma.
  • Clinical observation showed that the oral mucosal texture was smoother in artificial dermis with added epithelial cells at 4 weeks postoperation compared with artificial dermis alone.
  • We showed that healthy granulation tissue and neoepithelial formation in artificial dermis with epithelial cells was beneficial for the repair of oral defects.
  • Scraping oral epithelial cells and applying them to artificial dermis assisted in the early preparation of composite grafts and minimized requirement for donor sites.
  • This technique may improve the treatment of patients with oral benign tumors and early-stage squamous cell carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / surgery. Dermis / transplantation. Epithelial Cells / transplantation. Mouth Neoplasms / surgery. Skin, Artificial. Wound Healing
  • [MeSH-minor] Humans. Mouth Mucosa / surgery. Transplantation, Autologous

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20171593.001).
  • [ISSN] 1728-7731
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


87. Ozcan C, Apa DD, Aslan G, Gülhan S, Görür K: Mycobacterium tuberculosis infection within parotid gland Warthin tumor. J Craniofac Surg; 2008 Nov;19(6):1561-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mycobacterium tuberculosis infection within parotid gland Warthin tumor.
  • The second is a chronic, slow-growing, painless, and firm parotid mass mimicking a neoplasm.
  • Warthin tumor is a well-known benign neoplasm of the salivary glands.
  • It is the second most common tumor of the parotid gland.
  • Mycobacterium tuberculosis within Warthin tumor is also unusual.
  • Five cases with parotid gland tuberculosis within Warthin tumor were reported in the literature.
  • In this report, we present a new patient with parotid gland tuberculosis within the Warthin tumor.
  • We also discussed the possible mechanisms of development of infection within Warthin tumor.
  • [MeSH-major] Adenolymphoma / diagnosis. Parotid Diseases / diagnosis. Parotid Neoplasms / diagnosis. Tuberculosis, Oral / diagnosis
  • [MeSH-minor] Antitubercular Agents / therapeutic use. Biopsy. Contrast Media. DNA, Bacterial / analysis. Follow-Up Studies. Humans. Image Enhancement. Magnetic Resonance Imaging. Male. Middle Aged. Mycobacterium tuberculosis / genetics. Polymerase Chain Reaction. Tuberculoma / diagnosis

  • Genetic Alliance. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19098552.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antitubercular Agents; 0 / Contrast Media; 0 / DNA, Bacterial
  •  go-up   go-down


88. Gaitan Cepeda LA, Quezada Rivera D, Tenorio Rocha F, Leyva Huerta ER, Mendez Sánchez ER: Vascular leiomyoma of the oral cavity. Clinical, histopathological and immunohistochemical characteristics. Presentation of five cases and review of the literature. Med Oral Patol Oral Cir Bucal; 2008 Aug;13(8):E483-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascular leiomyoma of the oral cavity. Clinical, histopathological and immunohistochemical characteristics. Presentation of five cases and review of the literature.
  • Leiomyoma, a benign neoplasia arising from smooth muscle is an uncommon neoplasia of the oral cavity.
  • The most common histological subtype in the oral cavity is the vascular one.
  • To supplement information on vascular leiomyoma of the oral cavity (VLOC), we present cases of VLOC describing their clinical, histological, and immunohistochemical characteristics.
  • The age average of the cases was 40.6, however 3 out of our 5 cases were < or = 40 years old at the moment of their diagnosis.
  • Differential diagnosis of VLOC with fusocellular neoplasm is discussed.
  • [MeSH-major] Angiomyoma / pathology. Mouth Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18667980.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 23
  •  go-up   go-down


89. Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint HP, Rivera RS, Nakajima M, Naomoto Y, Nagai N: Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor. J Oral Pathol Med; 2007 Oct;36(9):550-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.
  • BACKGROUND: Keratocystic odontogenic tumor (KCOT), also known as odontogenic keratocyst, is a benign cystic neoplasm, which may be associated with nevoid basal cell carcinoma syndrome (NBCCS) and if it does, will occur as multiple cystic lesions.
  • Heparanase is an endo-d-glucuronidase enzyme that specifically cleaves heparan sulfate (HS) and the increase of its level in tumors promotes invasion, angiogenesis, and metastasis.
  • To compare the expression pattern of these cysts with non-tumorous odontogenic developmental cyst, dentigerous cyst was included.
  • [MeSH-major] Basal Cell Nevus Syndrome / enzymology. Glucuronidase / biosynthesis. Odontogenic Cysts / enzymology. Odontogenic Tumors / enzymology
  • [MeSH-minor] Dentigerous Cyst / enzymology. Gene Expression Regulation, Neoplastic. Heparan Sulfate Proteoglycans / metabolism. Humans. Immunohistochemistry. In Situ Hybridization. Neoplasm Invasiveness

  • Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17850439.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Heparan Sulfate Proteoglycans; EC 3.2.1.- / heparanase; EC 3.2.1.31 / Glucuronidase
  •  go-up   go-down


90. Bhutta MF, Dunk L, Molyneux AJ, Tewary A: Parotid pleomorphic adenoma with solitary renal metastasis. Br J Oral Maxillofac Surg; 2010 Jan;48(1):61-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Metastasising pleomorphic adenoma shows malignant clinical behaviour, and although it appears histologically benign, there may be unknown molecular features that determine its unusual ability to spread.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Kidney Neoplasms / secondary. Parotid Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Recurrence, Local / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 19386401.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


91. Eckardt AM, Kokemüller H, Flemming P, Schultze A: Recurrent ameloblastoma following osseous reconstruction--a review of twenty years. J Craniomaxillofac Surg; 2009 Jan;37(1):36-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The adequate therapy of ameloblastoma may require a compromise between the least destructive treatment possible of a benign tumour and a sufficiently radical method to prevent recurrences.
  • The primary reconstruction of bones and/or soft tissues, which is likely to be performed especially for benign processes is threatened by recurrences.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Reconstructive Surgical Procedures
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bone Transplantation. Child. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Mandibular Neoplasms / pathology. Mandibular Neoplasms / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery. Middle Aged. Retrospective Studies. Surgical Flaps. Young Adult

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19022680.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


92. de Ru JA, van Leeuwen MS, van Benthem PP, Velthuis BK, Sie-Go DM, Hordijk GJ: Do magnetic resonance imaging and ultrasound add anything to the preoperative workup of parotid gland tumors? J Oral Maxillofac Surg; 2007 May;65(5):945-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Do magnetic resonance imaging and ultrasound add anything to the preoperative workup of parotid gland tumors?
  • PURPOSE: To assess the additional value of magnetic resonance imaging (MRI) and ultrasound (US) to physical examination (PE) and fine needle aspiration cytology (FNAC) in the preoperative determination of the location and histology of parotid gland tumors.
  • PATIENTS AND METHODS: Prospectively, 99 patients with 77 benign and 22 malignant lesions were included; 82 underwent parotidectomy.
  • On PE, the location of the tumor was predicted.
  • Various characteristics and the presumed diagnosis were assessed.
  • Furthermore, the location of the tumor in relation to the facial nerve was predicted.
  • Cytology correctly predicted the benign or malignant nature of the tumor in all cases.
  • CONCLUSION: FNAC is the only accurate investigation for classifying a parotid gland tumor as benign or malignant.
  • Palpation and MRI are superior to US in predicting tumor location.
  • Because the results for palpation and MRI are almost equal, MRI should only be reserved for specific cases, and not routinely requested.
  • [MeSH-major] Adenolymphoma / pathology. Adenoma, Pleomorphic / pathology. Biopsy, Fine-Needle / methods. Lymphoma, B-Cell, Marginal Zone / pathology. Parotid Diseases / pathology. Parotid Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Facial Nerve / anatomy & histology. Female. Humans. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neoplasm Staging / methods. Parotid Gland / anatomy & histology. Parotid Gland / innervation. Physical Examination. Reference Standards. Single-Blind Method

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17448846.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Shen LC, Chen YK, Hsue SS, Shaw SY: Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma. J Oral Pathol Med; 2010 Mar;39(3):242-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Ameloblastoma is the most common clinically-significant epithelial odontogenic tumor, and is considered a benign but locally-aggressive tumor of the craniofacial region.
  • Osteonectin/secreted protein acidic and rich in cysteine (SPARC) is induced in response to a number of biological processes such as tumor growth and metastasis, whereas matrix metalloproteinases (MMPs) degrade the extracellular matrix and participate in various biological processes including tumor invasion and metastasis.
  • CONCLUSION: Our results suggest a putative association between SPARC and MMPs (especially MMP-9) in ameloblastoma to regulate tumor invasion.
  • [MeSH-minor] Adolescent. Adult. Cohort Studies. Endothelial Cells / pathology. Female. Fibroblasts / pathology. Follow-Up Studies. Gene Expression Regulation, Neoplastic / genetics. Humans. Male. Matrix Metalloproteinase 1 / analysis. Matrix Metalloproteinase 2 / analysis. Matrix Metalloproteinase 9 / analysis. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20070483.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Osteonectin; EC 3.4.24.- / Matrix Metalloproteinases, Secreted; EC 3.4.24.24 / MMP2 protein, human; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; EC 3.4.24.7 / MMP1 protein, human; EC 3.4.24.7 / Matrix Metalloproteinase 1
  •  go-up   go-down


94. Lin C, Li J, Lu N: [Analysis of 2161 cases of neoplasm in oral maxillofacial region in Xinjiang]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Sep;45(9):553-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of 2161 cases of neoplasm in oral maxillofacial region in Xinjiang].
  • OBJECTIVE: To investigate the incidence and constituent characteristic of neoplasm in oromaxillo-facial region in Xinjiang.
  • METHODS: A total of 2161 patients with benign or malignant oral-maxillofacial tumors diagnosed in Department of Dentofacial Surgery of the First Affiliated Hospital of Xinjiang Medical College from 1995 to 2009 were analyzed retrospectively.
  • RESULTS: Of the 2161 cases, 58.49% (1264/2161) was benign tumors, 33.13% (716/2161) malignant tumors, and 8.38% (181/2161) tumor-like lesions.
  • The most common benign tumors were pleomorphic adenoma, hemangioma, papilloma, adenolymphoma and ameloblastoma.
  • Squamous cell carcinoma constituted the majority of the malignant tumors.
  • The most common malignant tumors of salivary gland were adenoid cystic carcinoma.
  • The most common odontogenic tumors was ameloblastoma.
  • The most common sites of malignant tumors were tongue, lip, parotiod gland and buccal mucosa.
  • CONCLUSIONS: The common pathological type of oral and maxillofacial benign neoplasm and the most common sites of malignancy in Xinjiang region were similar to those of other places inside and outside the country.
  • Adenoid cystic carcinoma was more common than other salivary originated tumors.
  • There was more malignant tumors in Uygur nationality than in Han living in the same region.
  • [MeSH-major] Mouth Neoplasms / pathology
  • [MeSH-minor] Adenolymphoma. Adenoma, Pleomorphic. Ameloblastoma. Carcinoma, Adenoid Cystic / epidemiology. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. China / epidemiology. Face. Humans. Incidence. Mouth Mucosa. Odontogenic Tumors. Retrospective Studies. Salivary Gland Neoplasms

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21122451.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


95. Rajasekhar G, Mushtaq M, Vura NG, Shekar R, Kumar S: Condyloma acuminatum associated with odontogenic myxoma: a case report. J Maxillofac Oral Surg; 2009 Dec;8(4):384-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In oral cavity the condition manifests as soft pink nodules which proliferate and coalesce rapidly to form diffuse papillomatous clusters of varying size.
  • Odontogenic myxoma is a rare tumor of jaws which occurs in the tooth-bearing areas of the mandible and maxilla.
  • It is an uncommon, benign, but locally aggressive neoplasm.
  • This case report highlights a 17-year-old girl with two lesions in oral cavity with soft tissue growth on the palate which has been diagnosed as Condyloma Acuminatum, treated by surgical excision and a large swelling on the right side of the mandible in the same patient diagnosed as odontogenic myxoma where marginal resection was performed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Vener Dis. 1978 Dec;54(6):433-40 [581655.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1968 Oct;26(4):434-40 [5244772.001]
  • [Cites] Dermatol Surg. 2003 Mar;29(3):300-3 [12614429.001]
  • [Cites] Int J Oral Maxillofac Surg. 2008 Dec;37(12):1159-61 [18774261.001]
  • [Cites] Br J Vener Dis. 1983 Oct;59(5):325-6 [6311323.001]
  • [Cites] Jpn J Clin Oncol. 1996 Dec;26(6):393-7 [9001342.001]
  • [Cites] Sao Paulo Med J. 1997 Mar-Apr;115(2):1383-9 [9460298.001]
  • [Cites] J Clin Pathol. 1965 Mar;18:142-9 [14276146.001]
  • [Cites] Histopathology. 2004 Mar;44(3):216-21 [14987224.001]
  • [Cites] J Contemp Dent Pract. 2006 Feb 15;7(1):117-24 [16491154.001]
  • [Cites] J Am Dent Assoc. 2003 Mar;134(3):331-4 [12699047.001]
  • (PMID = 23139551.001).
  • [ISSN] 0972-8279
  • [Journal-full-title] Journal of maxillofacial and oral surgery
  • [ISO-abbreviation] J Maxillofac Oral Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3454105
  • [Keywords] NOTNLM ; Autoinoculation / Condyloma acuminatum / HPV-6 / Odontogenic myxoma / Palate / Young adult
  •  go-up   go-down


96. de Amorim RF, Silveira EJ, França MN, Guimarães Mdo C, Lima Júnior N, de Carvalho DR: A case of extensive maxillary benign cementoblastoma. J Contemp Dent Pract; 2010;11(3):056-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of extensive maxillary benign cementoblastoma.
  • AIM: The aim of the present paper is to report a case of benign cementoblastoma (BC) involving multiple maxillary teeth and discuss the importance of its diagnosis in clinical oral practice.
  • BACKGROUND: BC is a rare, benign odontogenic neoplasm of ectomesenchymal origin.
  • This neoplasm has characteristic radiologic and microscopic features, and it is intimately associated with the roots of teeth.
  • CASE REPORT: The intra-oral examination in a 21-year-old white man revealed a palatine growth in the premolar-molar region.
  • SUMMARY: In most cases, initial BC is asymptomatic and early diagnosis can be performed by routine radiographic examination.
  • CLINICAL SIGNIFICANCE: Because a benign cementoblastoma represents an odontogenic lesion, general practicing professionals must be able to identify the main features of this tumor.
  • Therefore, a brief update concerning the clinical and radiographic features of this unique tumor is also provided.
  • [MeSH-major] Maxillary Neoplasms / diagnosis. Odontogenic Tumors / diagnosis
  • [MeSH-minor] Bicuspid / pathology. Biopsy. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Molar / pathology. Palatal Neoplasms / diagnosis. Radiography, Panoramic. Tooth Root / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20461325.001).
  • [ISSN] 1526-3711
  • [Journal-full-title] The journal of contemporary dental practice
  • [ISO-abbreviation] J Contemp Dent Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, Farfan-Morales JE, Irigoyen-Camacho ME, Damián-Matsumura P: Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol; 2008 Aug;44(8):805-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastoma is the most frequent odontogenic tumor and is considered a benign, but locally invasive, neoplasm with variable clinico-pathological expression.
  • The salient finding was that expression of syndecan-1 was related to the histological subtype of tumors, as there was a lower expression in SA (40.2%) as compared to UA (49.7%) (p<0.05).
  • The lack of correlation between reduction of the syndecan-1 and Ki-67 index may be due to the different histomorphologies of both types of ameloblastoma, and more studies are necessary to better understand the role of this protein in the biological behavior of these tumors.
  • [MeSH-major] Ameloblastoma / metabolism. Ki-67 Antigen / metabolism. Neoplasm Proteins / metabolism. Syndecan-1 / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Down-Regulation. Female. Gene Expression. Humans. Immunohistochemistry. Male. Middle Aged. Mouth Mucosa / metabolism. Tooth Germ / metabolism. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207448.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Neoplasm Proteins; 0 / Syndecan-1
  •  go-up   go-down


98. Bologna-Molina R, Mosqueda-Taylor A, de Almeida-Oslei P, Toral-Rizo V, Martínez-Mata G: Peripheral desmoplastic ameloblastoma: histopathological and immunohistochemical profile of a case. Med Oral Patol Oral Cir Bucal; 2010 Nov;15(6):e846-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reports a new case of this unusual neoplasm in a 66 year-old woman in which the main complaint was an asymptomatic swelling located in the right body of mandible.
  • Histopathological findings were similar to the two previously reported cases of this tumor.
  • Positive immunohistochemical stain for laminin V and type IV collagen suggests an inductive effect of the epithelium over the stroma while the low index of p53 protein and Ki-67 expression in epithelium and stromal cells, as well as CD138 uniform positive-stain in epithelial cells, support the benign biological behavior of this lesion.
  • Including this new case, currently there are only three reports of this rare neoplasm.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20526273.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


99. Wang CP, Lee YC, Lou PJ, Yang TL, Chen TC, Huang CC, Ko JY: Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head neck cancer. Oral Oncol; 2009 Jul;45(7):615-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Except three patients with very narrow space or the presence of the tumor in the neopharynx, transnasal EGD could completely evaluate the upper digestive tract in 33 patients and found one patient with local recurrent hypopharyngeal cancer, seven patients with newly diagnosed hypopharyngeal cancer, four patients with esophageal cancer, and one patient with simultaneous hypopharyngeal and esophageal cancers, which were all successfully biopsied and proven microscopically.
  • One patient had a benign tumor on the epiglottis and the other NPC patient had extensive soft tissue necrosis in the pyriform sinus as a cause of dysphagia.
  • The present study indicates that unsedated transnasal EGD is feasible to confidently distinguish between functionally/anatomically-related dysphagia and newly growing tumors in the upper digestive tract, and to obtain biopsy specimens for pathological diagnosis from the tumors in a single session.
  • [MeSH-major] Deglutition Disorders / diagnosis. Endoscopy, Digestive System / methods. Esophageal Neoplasms / diagnosis. Hypopharyngeal Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Conscious Sedation. Feasibility Studies. Female. Head and Neck Neoplasms / pathology. Humans. Male. Middle Aged. Prospective Studies. Taiwan

  • Genetic Alliance. consumer health - Dysphagia.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Swallowing Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19027351.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


100. Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE: Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol Oncol; 2010 Feb;4(1):65-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
  • Here we describe a detailed analysis using gel-based proteomics in combination with mass spectrometry and immunohistochemistry (IHC) of the tumour interstitial fluids (TIF) and normal interstitial fluids (NIF) collected from 69 prospective breast cancer patients.
  • The goal of this study was to identify abundant cancer up-regulated proteins that are externalised by cells in the tumour microenvironment of most if not all these lesions.
  • To this end, we chose to use samples derived from a single tumour/benign tissue pair (patient 46, triple negative tumour), for which we had well-matched samples in terms of epithelial cell numbers, to generate the initial dataset.
  • [MeSH-major] Biomarkers / metabolism. Biomarkers, Tumor / metabolism. Breast Neoplasms / diagnosis. Neoplasm Staging / classification
  • [MeSH-minor] Body Fluids / chemistry. Calreticulin / metabolism. Chloride Channels / metabolism. Early Diagnosis. Electrophoresis, Gel, Two-Dimensional / methods. Female. Galectin 1 / metabolism. Humans. Immunohistochemistry. Peptide Elongation Factor 1 / metabolism. Peroxiredoxins / metabolism. Prognosis. Protein Disulfide-Isomerases / metabolism. Proteomics / statistics & numerical data. Thymidine Phosphorylase / metabolism. Up-Regulation






Advertisement